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ABSTRACT 
 
 
People with HIV infection are living longer as a result of advances in combination 
antiretroviral therapy. This increase in lifespan has been coupled with an increase 
in the prevalence of HIV associated neurocognitive decline (HAND). A central 
feature of this presentation is the impairment of executive functioning, and the 
aim of this study was to explore whether there is general impairment of this 
domain or whether there is an executive function profile (of deficits versus 
relatively preserved aspects of function) in people with HAND.  
Sixteen participants with HAND (mean age = 49.25 years, range 23 to 72 years) 
were recruited from an inpatient HIV-rehabilitation unit, and completed cognitive 
and executive function batteries.  
The executive function profile obtained at group level suggested impairments in 
working memory, verbal initiation, verbal inhibition, rule induction, and processing 
speed abilities. In contrast letter fluency and visuo-spatial switching scores were 
less affected.  
Case series analyses indicated that cognitive and executive functioning varied 
widely within the participant sample. However verbal initiation and inhibition were 
impaired in all profiles, indicating these impairments are prominent in the early 
stages of disease.  
The findings of this study indicate that it may be beneficial for clinicians to use 
executive function batteries when assessing for HAND, since a thorough 
assessment of this multi-faceted cognitive domain can support more informed 
clinical decision-making. Further, the study suggests which tests may be clinically 
useful in detecting executive function deficits in HAND. 
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1. INTRODUCTION 
 
 
Literature databases (PsychInfo, Pubmed and Science Direct) were searched for 
articles containing key terms relevant to the topic under investigation (e.g. ‘HIV’, 
‘cognitive impairment’, ‘executive functioning’). Abstracts from the results of these 
searches were screened and, where appropriate, full articles obtained. Chapters 
of relevant books were also screened. Finally, authors featuring prominently in 
the first two search phases were then used as search terms to elicit any further 
useful material. 
 
1.1 Epidemiology 
 
Human Immunodeficiency Virus (HIV) infection results in progressive decline of 
the body’s natural immune responses, thus leading to increased susceptibility to 
opportunistic infections and diseases. Advanced stages of decline are associated 
with Acquired Immunodeficiency syndrome (AIDS). 
 
1.1.1 Worldwide Prevalence 
The United Nations Programme on HIV/AIDS (UNAIDS, 2013) estimated that 
there are 35.3 million people globally living with HIV, and that there were 2.3 
million new infections in 2012. Because many people live for some time without 
knowing they are infected, other authors have given much higher figures of 
prevalence. For example Ellis, Langford, and Masliah (2007) put the figure of 
those infected at over 40 million, whilst Sharp and Hahn (2011) suggest 60 
million. The UNAIDS (2013) highlights that since the start of the epidemic in the 
early 1980s approximately 70 million people have been infected in total. Kumar 
and Clark (2012) note that since the first description of AIDS in 1981, and the 
identification of the causative organism, HIV, in 1983, more than 30 million 
people are thought to have died.  
 
Prevalence figures appear to vary significantly between different countries. It is 
believed that HIV originated in Sub-Saharan Africa, and this region is still the 
most affected by the disease today; 1 in 20 adults in this area has HIV and it 
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accounts for 69% of the total worldwide prevalence. Interestingly there has been 
a 42% decline in new infections in the Caribbean (the second most affected 
region in the world; UNAIDS, 2013). However Kumar and Clark (2012) note that it 
is Eastern Europe and parts of central Asia where infection rates have been 
rising sharply in more recent years. The authors also note the societal and 
economic costs are great, and that 33% of 15-year olds in countries with high 
prevalence and incidence rates will ultimately die of the infection. 
 
1.1.2 UK Prevalence  
It is estimated that over 96,000 people are infected with the disease in the UK 
(Health Protection Agency, 2012), however Kumar and Clark (2012) note that 
approximately one quarter of those infected are unaware, thus contributing to 
further onwards transmissions and poor clinical outcomes (with late diagnosis the 
most common cause of HIV-related morbidity and mortality). Kumar and Clark 
(2012) further note that in Western countries such as the UK, with falling death 
rates and continued new infections, prevalence may continue to increase though 
incidence rates may stay stable or fall. 
 
1.1.3 Transmission 
Kumar and Clarke (2012) note that heterosexual intercourse (vaginal and anal) 
accounts for the largest proportion of new infections globally. They also note that 
transfer of HIV appears to be more proficient when passed from male partners to 
female partners, and to the receptive partner in anal intercourse. In the UK 
homosexual transfer and heterosexual transfer account for new infections 
equally, however in Africa and Asia new infections are principally accounted for 
by heterosexual intercourse.  
 
Other significant modes of transmission include mother-to-child transfer, with up 
to 40% of children born to HIV-infected mothers also acquiring the virus without 
intervention (Kumar & Clarke, 2012); transmission may occur in utero, however it 
is more likely to occur peri-natally, with breast feeding being shown to double the 
risk of vertical transmission. Finally needle stick injuries and intravenous drug use 
with contaminated needles also contribute to the spread of infection. 
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1.1.4 History of HIV 
Sharp and Hahn (2011) note that AIDS was first discovered in 1981, following a 
period when large numbers of young homosexual men were observed to be 
dying of unusual opportunistic infections and tumours. A retrovirus (a type of virus 
which inserts its DNA into the host cell in order to replicate) now known to be HIV 
was identified in 1983 as the causal vehicle.  
 
Kumar and Clark (2012) note that there are two types of the virus, HIV-1 and 
HIV-2, with the former occurring more frequently. HIV-1 appears to have evolved 
from the simian immunodeficiency virus found in chimpanzees and reportedly has 
three strains – the first and most prominent is the M (main) strain. It is believed to 
make up 90% of all infections worldwide. Sharp and Hahn (2011) note that since 
it’s first identification over 30 years ago, the M group has infected 60 million 
people and resulted in more than 25 million deaths. (The other strains – ‘O’ and 
‘N’ are less studied due to their relatively smaller distribution).  
 
HIV-2 appears to have evolved from sooty mangabey monkeys and is reportedly 
not as virulent as HIV-1. It is principally found in West Africa, France, and 
Portugal. Kumar and Clarke (2012) note that HIV-2 is only 40% structurally 
similar to HIV-1, and although also associated with immunosuppression, it 
appears to be less malignant. Neither virus is pathogenic in its natural host 
(Sharp & Hahn, 2011).  
 
It is believed that HIV originated in sub-Saharan Africa (Gabon, Equatorial 
Guinea, Cameroon, and the Republic of Congo) in non-human primates and was 
transferred to humans in the late 19th or early 20th century (WHO, 2007). 
There are a number of theories explaining the transfer of the virus to humans. For 
example Hahn, Shaw, de Cook, and Sharp (2000) report evidence to suggest 
that humans may have been infected as early as the 1930s, after being exposed 
to animal blood and secretions during hunting, or by consuming contaminated 
meat. The AIDS epidemic did not occur until the end of the twentieth century, and 
Hahn et al. (2000) cite a number of social, economic, and behavioural factors 
which provided optimal conditions for the virus to reach epidemic proportions 
including social disruption, urbanisation, slavery, and prostitution. Others have 
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highlighted the roles of stigma and discrimination (UNAIDS, 2013), lack of 
education, and misconceptions about HIV (Leclerc-Madlala, Simbayi & Cloete, 
2009) as influential in facilitating the spread of the virus.  
 
Edward Hooper (1999) also attempted to account for cross-species 
contamination and, therefore, the spread of HIV. He hypothesised that 
vaccination trials containing chimpanzee and sooty mangebey kidneys carried 
out in the Belgian Congo in the late 1950s played a central role. However, Hahn 
et al. (2000) note that this hypothesis is not consistent with a stronger body of 
evidence indicating that certain strains of the virus originated 50 years before the 
trials were conducted. 
 
Finally the Duesberg hypothesis, a fundamental driver behind the ‘AIDS 
Denialism’ movement, (Duesberg, 1998) states that various non-infectious 
causes such as pharmaceutical and recreational drug use are the cause of AIDS, 
and that HIV only serves as a passenger virus.  However this controversial claim 
is thought to have lead to some devastating outcomes; in 2006 as a result of 
these ideas, Thebo Mbeki, a former South African Health Minister, promoted 
natural remedies such as garlic over the use of anti-retroviral medication. 
Chigwedere, Seage, Gruskin, Lee, and Essex (2006) estimate that this resulted 
in 365,000 deaths at the time. Consequently the Duesberg Hypothesis, which 
was never widely received, has been largely discredited by the scientific 
community. 
 
1.1.5 Natural History of HIV  
Classification systems attempt to track the progression of diseases from the point 
of exposure to the causal agent. The WHO (2007) classified the progression of 
HIV into the following three stages (please see Appendix A for fuller 
descriptions):  
 
i. Acute Infection Phase 
Approximately 2-4 weeks after exposure to the virus, 40-90% of individuals will 
experience extreme flu-like symptoms. These symptoms are often mistakenly 
attributed to other causes.   
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ii. Asymptomatic HIV Infection/Clinical Latency 
Infected individuals can remain asymptomatic for long periods. During this phase 
HIV infection reproduces at relatively low levels, and individuals are able to 
remain well without the use of medications.  
 
iii. HIV Disease & AIDS 
If untreated, HIV will develop into AIDS. In this phase immunity is severely 
impaired and there is a high risk of developing infections and tumours. These 
diseases can be fatal and life expectancy can be as little as one year. 
 
 
1.2 HIV Pathology 
 
It is thought that HIV attacks the central nervous system thus leading to, among 
other diseases, HIV associated neurocognitive decline (HAND). Masliah, 
DeTeresa, Mallory, and Hansen (2000) suggest that the brain is the second most 
frequently infected organ after the lungs. Fischer-Smith and Rappaport (2005) 
report that approximately 60% of individuals infected by HIV become 
neurologically impaired with causes including toxoplasmosis, opportunistic 
infections and neurologic disorders (e.g. tumours and strokes). These individuals 
often present with symptoms indicating neurotoxicity, neurodegeneration, 
inflammation, and consequently cognitive changes. McArthur et al. (2003) note 
that HAD, the severest form of HAND, is currently the most common form of 
dementia in those under the age of 60.  
 
Hult, Chana, Masliah, and Everall (2008) argue that in non-pathological 
circumstances CD4 +T lymphocyte cells, macrophages, and monocyte cells 
maintain immunity of the CNS. HIV infection attacks these cells and either 
destroys them or alters their functioning, thus leading to a gradual deterioration in 
immunity and, consequently, development of opportunistic infections and cancers 
(McArthur, Steiner, Sacktor & Nath, 2010). Further, since it is a retrovirus it is 
able to replicate itself, and Kumar and Clarke (2012) note that HIV is also a 
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lentivirus since there is often a delay in the onset of symptoms after the 
acquisition of infection. 
 
The blood brain barrier is highly selective however the Trojan Horse Hypothesis 
(Liu et al., 2002) suggests that HIV is able to infiltrate the barrier by targeting and 
corrupting immunity cells, and acting as a passenger being carried into the brain. 
This results in the blood brain barrier becoming inflamed and, consequently, 
functionally and structurally impaired.  Macrophages have many important roles 
including ridding the body of dead cells and playing a crucial role in initiating the 
body’s immune response. It is thought that in the case of HIV infection, 
macrophages not only become infected, but also become reservoirs of on-going 
virus replication. 
 
Microglia, cells specifically involved in supporting immunity of the brain, are 
thought to become infected through contact with infected macrophage cells and 
are also targeted by HIV as sites of replication. Hult et al. (2008) note that HIV 
infected migroglia produce neurotoxic substances which result in dendric damage 
and neuronal injury. 
 
Lindl, Marks, Kolson and Jordan-Sciutto (2010) note that these processes 
demonstrate the ‘direct’ mode of action that HIV employs. The authors argue that 
this process is also coupled with an ‘indirect’ mode of impact; direct injury leads 
to further inflammation as the immune system stimulates uninfected microglia in 
an attempt to curb additional injury. In support of this, Anthony and Bell (2008) 
note that HIV associated dementia appears to correlate with extent of neuro-
inflammation rather than with viral load or HIV encephalitis. 
 
Hult et al. (2008) note that damage to the CNS may be characterised into primary 
and secondary pathologies. Primary pathologies are thought to be those caused 
directly by the presence of the virus and have been explored above. The authors 
note that primary HIV neuropathology has been linked to a triad of impairments 
comprising cognitive, motor, and behavioural deficits.  Secondary pathologies are 
those occurring due to the immunosuppression resulting from HIV acquisition and 
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are termed ‘opportunistic infections’ e.g. lymphomas, Cryptococcus infections 
and progressive multifocal leukoencephalophy. 
 
It is worthy of note that the account provided above is not unproblematic since 
not all those infected with HIV show reproductive infection at autopsy. This has 
led some to hypothesize that reproduction of the virus may occur not in the CNS, 
but in the bone marrow where CD14+ CD16+ monocyte cells are produced (Ellis 
et al., 2007). Anthony and Bell (2008) note that since there has been limited 
opportunity to study the brain in the early stages of disease, there is still no 
conclusive evidence as to which cells harbour HIV at the stage of disease 
acquisition. However what is agreed is that, as the disease progresses, HIV 
encephalitis (HIVE) and opportunistic infections start to present. These conditions 
are associated with activated or infected microglia and microphage cells that 
release toxins, which in turn damage neurons and synapses.  Ellis et al. (2007) 
note that these toxins target the frontal cortex, the basal ganglia, the 
hippocampus and the white matter. 
 
Further, Lentz, Kim, and Lee (2009) note that neuroimaging has demonstrated 
that subcortical brain areas are targeted in the early stages while cortical areas 
affected later.  A number of authors have reported reduced volume of the basal 
ganglia in people with HIV infection (Berger & Arendt, 2000; Jernigan et al., 
1993). In support of these findings Thomson et al. (2005) found strong patterns of 
neurotoxic impact resulting from high levels of nacetylasperate (a key indicator of 
neuroaxonal damage) in the basal ganglia, but they also reported evidence of 
damage in the frontal neocortex and the white matter tracts connecting these 
regions - the fronto-striato-thalamo-cortical loops; this neurotoxicity was 
associated with cognitive impairment in their study.  
 
Woods, Moore, Weber, and Grant (2009) note that the virus may also impact 
other structures and neural systems. The authors suggest that this is because 
once it has crossed the BBB, the virus can affect synaptodenric injury through 
direct and indirect (neuroinflammatory) mechanisms (thus resulting in wide-
ranging damage as also concluded by Lindl et al., 2010). They further note that 
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the degeneration of the fronto-striatal loops impacts broader neural networks and 
thus results in the manifestation of cognitive deficits. 
 
 
1.3 Treatment 
 
Reportedly only one adult has ever been ‘cured’ of the infection (Hutter et al., 
2009). Another study in the New England Journal of Medicine (Persaud et al., 
2013) discusses the case of a baby who was treated with antiretroviral therapy 30 
hours after birth following exposure to the virus. The child at 30 months of age is 
reported to be virus free.  
 
In spite of these two cases, there is strong consensus within the medical 
community that there is currently no cure for HIV infection. The introduction of 
antiretroviral therapy (ART) in 1987 appeared to change the prognosis of those 
with HIV, however it was quickly realised that single-drug therapy was unable to 
supress viral mutation, and thus often failed to result in longer-term benefits (Ellis 
et al., 2007). 
 
It was discovered that for treatment to be effective (i.e. to prevent virus mutation 
and therefore the development of drug resistant strains) more than one 
antiretroviral drug needed to be taken. Consequently in 1996 combination 
antiretroviral therapy (cART, also known as highly active antiretroviral therapy – 
HAART) was introduced. The WHO (2008) notes that if followed regimentally, 
cART can result in near-complete suppression of HIV replication, a reduction in 
onward transmissions and the development of opportunistic infections, and 
improved health outcomes. McArthur et al. (2010) note that treatment can consist 
of 3 or more antiretrovirals, with certain drugs being more effective at crossing 
the blood brain barrier. Mitchell (2004) also notes that certain combinations are 
thought to be more effective in suppressing CSF HIV-RNA and therefore 
impacting impairments associated with HIV associated neurocognitive decline. 
 
Although the advent of cART has changed the classification of HIV from a fatal 
condition to a chronic lifelong condition (Kumar & Clarke, 2012), a number of 
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issues need to be held in mind. Firstly the administration of drug therapy is often 
a complex issue, with infected individuals often struggling to tolerate the short-
term (e.g. diarrhea, rashes, and vomiting) and long-term (e.g. lipodystrophy) 
effects of the drugs (Volberding, 2003). Secondly, adherence can be difficult for 
some people to maintain due to an often large number of drugs and complicated 
dosage regimes. Thirdly, Anthony and Bell (2008) note that cART does not cure 
an individual of HIV and the virus will continue to reside in sanctuary sites even in 
those who adhere strictly to their medication protocols. The CNS is one of the key 
sanctuary sites for the virus due to the restricted immune surveillance of this 
area. The failure of cART to completely rid the body of the virus has a number of 
consequences including the development of drug resistant viral strains. 
 
Taking a broader perspective, Kumar and Clark (2012) note that global estimates 
indicate that only a quarter of those who need treatment are able to access it. 
The authors further note that for each person starting treatment, there are 
approximately two new infections, thus indicating the growing size of the problem. 
It is also worthy of note that cART is the global standard of care and access in 
areas with the highest levels of need (sub-Saharan Africa) is extremely limited; 
The UNAIDS (2013) estimated only 8 million people worldwide have access to 
anti-retroviral drugs. 
 
1.3.1 Has the Advent of cART Influenced the Neuropathology of HIV? 
Anthony and Bell (2008) note that since the advent of cART in the developed 
world, individuals no longer routinely progress from the asymptomatic phase 
directly through to AIDS. However the authors also note that recent evidence 
suggests that the drugs have not only influenced the incidence and clinical 
course of the disease, but also the neuropathology.  
 
Opportunities for exploring the impact of HIV on neuropathology in the cART era 
have been limited, principally because the treatment has reduced the number of 
HIV-associated deaths in the early stages of disease. Those who have died are 
thought to have done so due to other causes such as associated risk factors (e.g. 
drug overdoses) or comorbid illnesses and infections (e.g. Hepatitis C). In 
support of this, neuropathological investigations into such cases have highlighted 
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increased inflammation in the absence of infection caused by HIV or other 
opportunistic viruses (e.g. Ellis et al., 2007). 
 
However Anthony and Bell (2008) note that in spite of this, there are strong 
arguments to suggest that cART has had an impact on the neuropathological 
profile of HIV. They cite evidence to suggest that the areas of infection appear to 
have changed since the pre-cART era; this era saw inflammation in the basal 
ganglia, however the cART era has seen infection and inflammation in the basal 
ganglia, the hippocampus and the fronto-striatio-cortical loops.  Consequently 
HIV is no longer associated solely with damage to the sub-cortical regions, but 
also with damage impacting cortical regions and circuits.  
 
Anthony et al. (2006) further report their study showed that neurodegenerative 
proteins (hyperphosphorylated Tau) can be seen in the normal aging process, but 
not at the high levels found in people with Alzheimer’s disease and in those 
treated with cART. Therefore the authors conclude that the levels may be linked 
to accelerated neurological decline in these two groups.  
 
In support of this, Valcour, Skikuma, Watters, and Sacktor (2004) also reported 
high levels of proteins and suggest that older groups with HIV present with 
neurocognitive impairments not found in younger controls. The authors argue that 
this may be due to the toxicity of drugs used in cART, or due to the presence of 
co-factors such as hepatitis. They note that it is unlikely that ageing with HIV is a 
causal factor, as patients with HIV lived for approximately 15 years in the pre-
cART era and showed no evidence of increased levels of proteins. Consequently 
the authors conclude that elevated levels of these proteins appear to be unique to 
the period of cART, and that the resulting levels of inflammation in certain brain 
regions are similar to those found in sufferers of AIDS.  
 
As mentioned the virus is able to hide in areas where immune-surveillance is 
poorer (such as the brain).  Anthony and Bell (2008) note that since cART has 
increased the lifespan of those infected with HIV, this has resulted in certain sites 
having longer exposure to the virus and, again, the evolution of drug resistant 
strains. 
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1.4 HIV-associated Neurocognitive Decline (HAND) 
 
The neuropathology resulting from HIV infection can lead to a number of 
impairments characterised by varying degrees of behavioural, cognitive, and 
motor difficulties. This triad of impairments is known as HAND.  
Prevalence estimates of HAND vary greatly from 30% (Lindl et al., 2010), to 50% 
(Gannon, Khan, & Kolson, 2011) to 60% (Fischer-Smith & Rappaport, 2005), 
though there is general agreement that prevalence of the severest form of 
impairment (HIV associated Dementia) has greatly reduced since the advent of 
cART (Sacktor, 2002). 
 
1.4.1 Categorisation of HAND 
Navia, Jordan and Price (1986) provided one of the earliest reports of HIV 
associated Dementia (HAD), and labelled the combined presentation of cognitive 
impairment, motor dysfunction, and behavioural changes as ‘AIDS Dementia 
Complex’; however Catlan and Burgess (1996) criticised the term for assuming 
these impairments formed a distinct syndrome.  
 
In 1991 The American Academy of Neurology AIDS task force formulated a two-
tiered classification system consisting of ‘HIV associated dementia’ (which 
included behavioural, motor and psychological difficulties) and ‘minor cognitive 
motor disorder’ for those presenting with less severe impairments (Woods et al., 
2009). In 1995 an additional category of ‘sub-syndromic neuropsychological 
impairment’ was included to capture those presenting with mild cognitive deficits 
but with no impairment in activities of daily living (Grant & Atkinson, 1999). 
However Griffin and Gerhardstein (2010) criticised these early attempts at 
classifying HAND due to their poorly defined categories, which resulted in a lack 
of specificity between degrees of cognitive deficit.   
 
Other attempts have also been made to formulate a diagnostic system, with the 
most recent and widely accepted being formulated in Frascati, Italy by the 
National Institute of Health (Antinori et al., 2007). This classification framework 
ranges from ‘no impairment’ through to ‘dementia’. It attempts to take account of 
advancements in neuropsychological assessment tools and treatment protocols, 
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in addition to considering the impact of co-morbid conditions (Griffin & 
Gerhardstein, 2010): 
 
i. Asymptomatic Neurocognitive Impairment (ANI) 
Approximately 30% of HIV suffers present with mild neurocognitive difficulties 
which are thought to have a minimal impact on every day functioning (McArthur 
et al., 2010). 
 
ii. Mild Neurocognitive Disorder (MND) 
Reportedly found in 20-30% of individuals (Sacktor, 2002) who present with mild 
to moderate difficulties in two or more cognitive domains, and some difficulties in 
everyday functioning. McArthur et al. (2010) highlight that those in this category 
often present with poor medication adherence and therefore increased morbidity 
and mortality risks. 
 
iii. HIV Associated Dementia (HAD) 
Reportedly found in approximately 1-2% of HIV sufferers (McArthur et al., 2003). 
This presentation is characterised by moderate to severe difficulties in two or 
more cognitive domains, severe difficulties with activities of everyday living, and 
decreased survival rates (McArthur et al., 2010). 
 
1.4.2 Has cART Impacted the Incidence & Prevalence of HAND? 
As discussed in section 1.3.1, a number of authors have commented on the 
impact of cART on the prognosis of those infected with HIV whilst others have 
argued that the brain is a sanctuary site for the virus. Letendre et al. (2008) argue 
cART may not be neuroprotective since some antiretrovirals are unable to cross 
the blood brain barrier, and are therefore unable to effectively curb viral 
replication in the brain. Consequently it is likely that some individuals may go on 
to develop drug resistant viral strains, thus leading to increased viral replication 
and decreased CD4 cell counts.  
 
In support of this argument Heaton et al. (2010) found that 44% of those treated 
with drug therapy continue to show viral replication and CNS inflammation. This 
inflammation is thought to be implicated in the pathogenesis of HAND.  In fact 
Page 13 of 183 
this study found that prolonged immunosuppression is linked to a higher risk of 
HAND even after cART related immune-recovery, lending further support to 
research highlighting that HIV continues to exist in sanctuary sites. Further 
Robertson et al. (2007) note that resistance to antiretrovirals and the increase in 
survival rates of people with HIV may mean that the brain continues to be 
exposed to both the direct and indirect effects of the infection. This argument is 
inline with those posited earlier suggesting the prolonged survival of those with 
HIV lengthens the brain’s exposure to the virus.  
 
Further Tozzi et al. (2007) note that neurocognitive decline was not reversed in 
62% of individuals who had been treated with cART for 5 years. They also found 
that CD4 counts, viral load, age, and stage of HIV were not correlated with 
neurocognitive deficits thus lending support to the findings of Anthony and Bell 
(2008) who note that HAD appears to correlate with neuro-inflammation rather 
than directly with viral load or HIV encephalitis. 
 
In contrast however, Cysique et al. (2007) reported 41% of their sample showed 
improvements in cognition at 48 week follow-up. Further Robertson et al. (2010) 
tested individuals who had discontinued cART. Improvements in cognitive 
functioning were maintained at 24, 48, 72 and 96 week after discontinuation. The 
authors note however that practice effects may have accounted for a proportion 
of their findings. A recent systematic review conducted by Joska, Gouse, Stein, 
and Flisher (2010) noted that eleven of the 15 studies entered into the analyses 
reported improvements in cognition. The authors concluded that although it is 
likely cART improves cognition, elimination of all impairments may not be 
possible. However the findings of this study may not be robust enough to draw 
firm conclusions given that the average study timeframe was only six months, 
and also given the small number of studies entered into the final analysis. 
 
A longitudinal research design was employed to examine the effects of cART on 
cognitive performance by Hayman-Abello (2007) who reported that 386 adults at 
different disease stages were tested at baseline and 180 tested again at follow-
up. Those on cART were found to score higher on cognitive measures than those 
not engaged in therapy. Longitudinal analyses utilising reliable change indices 
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found that at follow-up 65% of the HIV group had stable cognitive profiles, 10% 
demonstrated improvements, and 26% demonstrated decline. The study also 
reported however that the long-term effects of cART on cognitive status were 
mediated by factors such as initial cognitive impairment level, and estimated IQ. 
 
Finally, exploration of the existing evidence base also highlights some differences 
in Pre- and Post-cART era cognitive profiles. Heaton et al. (2011) note that Pre-
cART impairments were characterised by deficits in processing speed and motor 
skills, however Post-cART profiles appear to show evidence of additional 
difficulties with executive functioning and new learning. 
 
1.4.3 The Validity of the Frascati Classification Framework 
Despite the popularity of the classification system developed by Antinori et al. 
(2007) a number of authors have recently questioned its utility.  Robertson et al. 
(2007) have commented that the framework does not adequately account for 
cognitive fluctuations, and also that there is a no account of corresponding 
neurological biomarkers. 
 
The category of ANI has attracted particular criticism. Glissen, Price and Nilsson 
(2011) highlight that studies have reported on the increasing numbers presenting 
with symptoms indicative of this level of impairment. However the authors 
question the utility of including this category in the classification framework since 
it does not require evidence of functional impairment. However Heaton et al. 
(2011) argue that the category usefully captures those who are yet unaware of 
emerging difficulties and may be at risk of further decline. In response Glissen et 
al. (2011) highlight the ethical implications of labeling those who do not present 
with significant degrees of cognitive difficulties, or any functional deficits, in 
clinical settings. This perspective casts doubts over the ecological validity and 
necessity of the construct, given that there is limited clinical relevance (Torti, 
Foca, Cesana, & Lescure, 2011). The authors also question the specificity of the 
category after reporting that 16% of the general population would be classified as 
impaired under the current criteria. 
 
This leads the discussion to consider broader criticisms of the way diseases are 
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socially constructed, such as those posited by authors such as Sontag (1991), 
who highlight that particular constructions can distort the truth about a disease 
(by labeling a particular presentation as an ‘impairment’ when it does not ‘impair’ 
an individual in any way).  She also highlights that thinking about an illness can 
cause more suffering than the illness itself. This is particularly relevant in this 
case given the stigma reported by sufferers of HIV, and the additional stigma that 
may result from this second label. This situation is further exacerbated by the lack 
of treatment/support protocols in place for those who are diagnosed with ANI. 
 
Further, to the best of the author’s knowledge, there is currently no research 
evidence indicating that those presenting with ANI are at increased risk of 
additional impairment, and thus there is a need for research on the construct’s 
predictive validity. 
 
 
1.5 HAND & Demographic Considerations 
 
1.5.1 Gender 
According to the WHO (2008) 50% of those living with HIV globally are women. 
However there are some regional variations e.g. in Sub-Saharan Africa Women 
constitute 60% of the HIV population, however in the UK between 2001 – 2013 
only 17% of those diagnosed with HIV were women (UNAIDS, 2013). 
 
Most research in this area is conducted with male participants since they are the 
most infected group in the Western world (Fox-Tierney Ickovics, Cerreta, & 
Ethier, 1999). Failde-Garrado, Alvarez, and Simon-Lopez (2008) note that female 
participants are often excluded from research in the medical field to ensure 
homogeneity of samples. However the authors question whether it is valid to 
generalise norms obtained from studies using principally male participants to the 
female population. The authors also note that there has been an increase in the 
incidence, and therefore prevalence, of HIV in women in recent years but this has 
not been coupled with an increased exploration of the neuropsychological 
characteristics of HAND in female groups. The authors further argue that females 
with HIV may be more vulnerable to cognitive impairment due to complex pre-
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morbid histories.  
 
Mason et al. (1998) found differences between HIV+ and HIV – women in motor 
speed, verbal memory, and attention. Durvasula, Miller, Myers, and Wyatt (2001) 
also reported differences in psychomotor speed. Further Maki et al. (2009) 
reported that women with HIV demonstrated greater deficits in verbal learning, 
delayed recall, and working memory than their male counterparts after being 
matched for important variables (e.g. stage of disease). 
 
Failde-Garrado et al. (2008) conducted a study to compare patterns of 
neuropsychological impairment between male and female participants. Deficits 
between genders did not differ strongly enough to reach levels of significance 
however the authors noted that females showed a trend towards slightly higher 
rates of impairment (51.9% in males and 54.8% in females). Further the authors 
also found that although male participants presented with higher levels of 
impairment in visual memory, attention and abstract reasoning, females showed 
higher levels of impairment in psychomotor speed/attention and verbal memory 
for prose. 
 
1.5.2 Age 
The likelihood of developing any dementia increases with age in the normal 
population, with 1 in 20 over the age of 65, and 1 in 5 over the age of 85 
predicted to develop, for example, Alzheimer’s disease (Department of Health, 
2009a).  
 
Valcour et al. (2004) note that although the advent of cART has increased the life 
expectancy of those with HIV, the implications of long-term infection and the 
cumulative toxic effects of antiretroviral therapy, in addition to age related 
vulnerability to dementia, warrants cause for concern. Their study reported higher 
rates of HAD in older participants, with this group also presenting with higher 
rates of cardiovascular diseases, other comorbid conditions, side effects from 
medications to treat these conditions, and less resilient immune systems.  
 
Others have noted that acquiring HIV later in life is linked to poorer outcomes 
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both in terms of greater risks in progression to AIDS (Belanger, Meyer, Carre`, 
Coutellier & Deveau, 1997) and in terms of poorer responses to cART (Kaufmann 
et al., 2013). 
 
In conclusion Gonzelez and Cherner (2008) note that normal ageing and HIV 
may increase vulnerability to neurocognitive decline. In terms of the dual effect on 
particular cognitive domains, Grant (2008) and Gonzelez and Cherner (2008) 
note that although language skills do not sharply decline with age, areas that are 
more vulnerable include reaction time, psychomotor speed, and the ability to 
solve complex problems. 
 
1.5.3 Education 
Grant (2008) highlights the positive impact of years of education on test 
performance. Particularly, he notes that exposure to education renders better 
performance on verbal fluency tests and those that require strategic planning. 
Grant notes that factoring in the impact of education is important and 
recommends making reference to norms developed with healthy controls with 
comparable years of education to ensure any deficits can be fairly attributed to 
the impact of HIV, rather than the impact of lower levels of education. 
However Manly et al. (2011) note that years of education are an inadequate 
measure of educational opportunity and exposure, and that quality of education is 
more important. They argue that reading level is a reliable measure of this after 
reporting that their study found reading ability was discrepant from number of 
years of schooling, and had a stronger relationship to neuropsychological test 
performance. 
 
1.5.4 Cognitive Reserve 
Stern (2000) observes it has been repeatedly suggested that degree of brain 
pathology/damage is not directly proportional to cognitive and behavioural 
manifestation of that damage.  Vance et al (2014) have suggested that such 
disparities can be understood in terms of the cognitive reserve hypothesis.  
Cognitive reserve refers to the amount of injury the brain can sustain without any 
impact on functioning. Stern notes that two models, which are not exclusive, have 
broadly conceptualized the construct. The first is the brain reserve capacity 
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model and the second the cognitive reserve model. The brain reserve capacity 
model suggests that those with larger reserve ability are able to tolerate a high 
degree of pathology before the onset of symptoms. The cognitive reserve model 
however highlights the role of cognitive processes in curbing the impact of 
pathology through the ability of cognitive networks. Morgan et al. (2012) note that 
cognitive reserve is operationalized as verbal IQ, academic achievement or 
occupational status. They further argue that in individuals with HIV, the cognitive 
reserve model would suggest the level of synaptodendric impairment at which an 
individual with high cognitive reserve develops HAND would be significantly 
greater in comparison to an individual with lower levels of cognitive reserve 
capacity. This hypothesis has indeed materialized in the findings of, for example, 
Pereda et al (2000) who reported higher levels of impairment in multiple cognitive 
domains in those with lower levels of cognitive reserve.  This study utilized 
multiple markers of cognitive reserve including years in education, educational 
achievement and estimates of pre-morbid ability and therefore the conclusions 
drawn may be considered robust.  
 
A further study, by Morgan et al (2012) attempted to explore the role of cognitive 
reserve in vulnerability to developing HAND, and also concluded that individuals 
with low cognitive reserve levels were more likely to develop and experience 
cognitive and functional deficits than those with high cognitive reserve markers. 
This study also used multiple markers of cognitive reserve (years of education, 
verbal IQ level, and occupational status) in addition to a measure of reading 
ability. As argued above, this is a useful measure of quality of educational 
exposure; the benefits of this measure over other measures of educational 
exposure were discussed above.  Finally Patel et al (2013) reported that cognitive 
reserve is a robust predictor of performance in attention/working memory and 
verbal fluency. 
 
1.5.5 Culture & Ethnicity 
Most research into diseases takes place in Western countries. However the 
highest prevalence rates are in other regions; as mentioned earlier sub-Saharan 
Africa has the highest number of people living with HIV, the highest number of 
new infections, and the highest number of AIDS related deaths (UNAIDS, 2013). 
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This discrepancy may result in people from all over the world, with contrasting 
cultural experiences, being assessed with tests and norms developed with 
Western populations. 
 
Manly et al. (2011) note that validation of assessment tools accounting for 
cultural factors has started to take place recently. However the authors also note 
that this normative data, whilst being a step in the right direction, may not always 
be useful since samples often exclude HIV negative candidates who may be at 
high risk of contracting the infection e.g. intravenous drug users or those with 
mental health difficulties. 
 
Further the authors reported that in their study, demographic factors accounted 
for a large proportion of the variance in tests of psychomotor speed and 
executive function between HIV + and HIV – participants. Of particular 
importance were factors associated with ethnicity, and quality of education. The 
influence of culture and education are important considerations since it has been 
well documented that those from ethnic minority backgrounds, and those with 
poorer educational experiences often perform poorly on cognitive measures and 
are therefore more vulnerable to false-positive diagnoses. Manly et al. report that 
in their study they found that reading level was a strong indicator of quality of 
education in ethnic minorities, which in turn also had the strongest impact on 
variance in test scores - more than HIV status and years of education.  
 
In line with Manly et al.’s study, Rohit et al. (2007) reported that specificity for 
detection of impairment increased by 20% in African American participants when 
cognitive test scores were adjusted for reading level. The authors also note that 
the same pattern was not found among American participant of European origin. 
 
1.6 HAND & Risk Factors 
A number of authors, including Patel et al (2013), have argued that there is a high 
prevalence of comorbid conditions amongst the HIV population, each of which 
increases vulnerability to, and severity of, cognitive impairment. Hepatitis C is 
discussed separately in section 1.7 and mental illness in section 1.8 due to their 
high prevalence in those with HIV. Age, also known to increase vulnerability to 
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cognitive impairment was discussed in section 1.5.2.  However Patel et al (2013) 
highlight other significant risk factors which increase vulnerability to impairment 
including vascular diseases and substance use. Their study used a ‘risk severity 
score’ based on the aggregated effects of various risk factors including age, 
vascular disease, substance use, and cognitive reserve. This risk score was 
found to be predictive of cognitive test outcomes on measures of learning and 
memory, executive functioning, verbal fluency and motor functioning. Particularly, 
the risk severity score was predictive of memory and verbal fluency in older 
participants, and of working memory and executive function deficits in younger 
participants. This study thus highlights that risk cannot be ignored when exploring 
cognitive deficits in HIV.  
 
Further Anand, Springer, Copenhaver, and Altice (2010) explored the reciprocal 
relationship of risk factors and HIV related cognitive impairment; they argue that 
as impairment increases, ability to self-care declines (e.g. take medication, avoid 
risk-taking, etc.), thus further negatively impacting cognition.  
 
1.7 HAND & Hepatitis C 
 
Rates of Hepatitis C are particularly prevalent in those with HIV due to the 
common modes of transmission (Sherman, Rouster, Chung & Rajicic, 2002). 
However Rotman and Liang (2009) note that prevalence data of HIV/HCV varies 
widely between studies, and that this is because the mode of exposure greatly 
impacts the likelihood of transmission. In intravenous drug users who are also 
HIV+, prevalence rates are reportedly as high as 93%, however transmission 
through sexual intercourse is somewhat inefficient, and consequently only 10% of 
transmissions occur in this way. 
 
Studies have found poorer global performances on neuropsychological 
assessments in HIV+/HCV+ participants in comparison to those who are HCV+/ 
HIV- (e.g. Letendre et al., 2007).  
 
Further, Thein et al. (2007) reported higher rates of subtle impairments in 
attentional skills in HIV/HCV co-infected participants in comparison to HIV+ only 
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participants. However the study was conducted with a relatively small sample (45 
participants) and this may explain why the difference did not reach significance.  
Further, Ryan, Morgello, Isaacs, Naseer, and Gertis (2004) reported findings 
indicating that those co-infected with HIV and HCV were more likely to have 
executive function deficits. 
 
 
1.8 HAND & Mental Health 
 
1.8.1 General Mental Health 
Anand, Springer, Copenhaver and Altice (2010) highlight the reciprocal 
relationship that HIV can have with mental health difficulties, both in terms of 
increasing vulnerability to contracting the virus, and in terms of developing 
difficulties after diagnosis. The authors further note that factors such as mental ill-
health can reduce medication adherence. This can lead to increased morbidity 
and mortality.  
 
Conversely, in their longitudinal study Prince, Walkup, Akincigil, Amin, and 
Crystal (2012) found that the odds of contracting HIV in participants with and 
without serious mental illnesses did not differ. In fact the authors go on to note 
that their study found that people with serious mental illnesses were 23% less 
likely than people without to receive a positive HIV diagnosis. 
 
1.8.2 Psychosis & Severe Presentations 
HIV prevalence rates for the general population are thought to be approximately 
0.87% (Perälä et al., 2007). Cournos and McKinnon (1997) note that rates of HIV 
infection in those with schizophrenia are estimated to be between 4% and 23% 
and are therefore much higher. 
 
Angelino and Treisman (2008) argue that schizophrenia can impact executive 
functioning, and consequently result in excessive risk-taking behaviors and 
difficulties in negotiating safe sex practices. This coupled with the often 
downward spiral in social and economic circumstances experienced by sufferers 
of schizophrenia can result in individuals finding themselves in situations where 
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they are vulnerable e.g. involved in coercive sexual situations. 
 
1.8.3 Mood 
Nakasujja et al. (2010) note that depression is more frequently observed in those 
with HIV than any other mental health difficulty, and Tucker, Buram, Sherbourne, 
Kung, and Gifford (2003) estimate that rates can be as much as 2-3 times higher 
than those observed in the general population. Others have reported that the 
incidence of depression increases as HIV progresses (Lyketsos et al., 1996). 
 
However Carter, Rourke, Murji, Shore, and Rourke (2003) note that in their study 
of cognitive deficits in HIV, depression was not significantly related to test scores. 
Interestingly Castellon et al. (2006) argue that depression is a multi-dimensional 
construct; their study found that motivation, a commonly used indicator of 
depression, was found to be significantly linked to verbal memory, executive 
functioning, and motor performance. As these cognitive domains have also been 
highlighted as key areas of impairment in those with HIV, further research is 
needed to account for the variance attributable to each factor individually. 
 
1.8.4 Anxiety 
Ferrari, Lapp and Peretti (2011) note that cognitive difficulties are often reported 
in those suffering from severe anxiety and anxiety disorders. However Prejean 
(1998) compared the neurocognitive performance of those with HIV and those 
without, whilst matching the two groups for anxiety level; he found that the two 
groups did not differ in terms of their neurocognitive functioning, thus failing to 
find a relationship between cognitive dysfunction and anxiety.  
 
However Micali, Zirilli, and Abbate (2011) conducted a longitudinal study of HIV+ 
men. They reported evidence to suggest that changes found between baseline, 6 
month follow-up and 18-month follow up scores were indicative of a strong 
relationship between increased anxiety and reduced cognitive performance. The 
authors suggest that one hypothesis about this relationship is that accelerated 
disease may result in particular psychiatric disorders such as anxiety. However 
given the strong body of research indicating the impact of anxiety on cognition in 
the general population, an alternative hypothesis may be that anxiety accelerates 
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dysfunction in whose who are HIV+; further research is required to inform the 
debate. 
 
 
1.9 Neuropsychological Assessment & HAND 
 
Blanch, Munoz-Moreno, Reverte and Ayuso-Mateos (2012) and Nath et al. 
(2008) note that even though cART has led to a sharp decrease in HAD, other 
forms of HAND are rising in prevalence. Blanch et al. (2012) note that 
neurocognitive changes can be detected in the very early stages of HIV infection, 
and since HIV is associated with a number of adverse consequences including 
poor quality of life and progression to AIDS if not properly managed, there has 
been much interest in early detection of neurocognitive deficits in this group. 
 
As Grant (2008) and Woods et al. (2009) note, neuropsychological assessment 
can offer: 
1. Detection and assessment of the extent of cognitive difficulties; 
2. Profiling cognitive strengths and weaknesses to develop supportive strategies 
to maintain current levels of functioning, and also to lessen the impact of 
deficits on day-to-day functioning; 
3. Provide a means for monitoring changes in neuropsychological status that 
may be related to treatment and/or disease progression; 
4. Support decisions about the appropriateness of care plans e.g. adherence to 
complex medication regimes. 
 
Carey et al. (2004) have noted that measures used to screen for other types of 
dementia (e.g. Mini Mental State Examination; Folstein & Folstein, 1975) have 
not demonstrated sensitivity to the earliest stages of HAND. The authors argue 
that this may be because the MMSE was devised with cortical dementias in mind 
(e.g. Alzheimers) and thus assess cognitive skills such as naming and praxis 
rather than skills associated with prefrontal-striatal (sub-cortical) areas (e.g. 
information processing, executive functioning, and working memory). 
 
In light of this Power, Selnes, Grim, and McArthur (1995) devised the HIV 
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Dementia Scale which has demonstrated superior sensitivity and specificity in 
comparison to other brief measures since it assesses deficits associated with 
subcortical dementias describe above. However Richardson et al. (2005) have 
argued that even this measure is not sensitive enough to the earliest signs of 
impairment in HAND. Other attempts at developing brief measures have also 
been made (e.g. International HIV Dementia Scale, Sackter et al., 2005) with 
mixed results, and it has long been argued that comprehensive batteries have 
better rates of sensitivity and specificity than screening measures when 
considering a diagnosis of any dementia. 
 
1.9.1 The General Profile of HAND 
As mentioned above subcortical functions, in addition to some cortical areas, are 
affected by HIV. However Schouten, Cinque, Gisslen, Reiss and Portegies 
(2011) note that the profile of HAND is still principally subcortical in nature since 
the most impaired domains are executive functioning, attention and new learning. 
 
Grant (2008) and Nath et al. (2008) note that in the early stages difficulties in 
speed, motor functioning and attention are evident.  As impairment further 
increases mental slowing, fine motor movements, gait disturbances and short-
term memory difficulties become apparent. 
 
Woods et al. (2009) note that the scattered nature of HIV associated pathology 
may present difficulties to neuropsychologists attempting to identify profiles of 
cognitive deficits. Cherner et al. (2007) provides some guidance on the issue and 
suggest that the following should be assessed in those presenting with HAND (i) 
attention and working memory (ii) executive functioning (iii) language (iv) memory 
(v) motor skills and (vi) processing speed. 
 
The following sections will provide brief summaries of literature found on the 
impact of HIV on key cognitive domains. However Levine et al. (2008) provide a 
cautionary note that the performance of any particular skill will usually require 
multiple cognitive abilities to be intact for successful execution. Consequently the 
sections below are ‘artificially’ divided to enable an assessment of the current 
literature.   
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1.9.2 Attention & Information Processing Speed 
Levine et al. (2008) note that attention is a multifaceted skill and summarising the 
current evidence base can be difficult since there is a lack of consistency in 
definitions and methods of assessment.  
 
To provide some clarity Grant (2008) notes that attention is a complex ability that 
is constructed of many individual processes including orientating oneself to a 
stimulus, choosing it whilst ignoring others, and maintaining and shifting focus 
when necessary.  
 
In HIV simple attention is reportedly preserved when assessed on tests such as 
Trails A (Grant 2008) except in the case of advanced disease. However tasks 
which involve more complex attention (e.g. divided and sustained attention), 
especially under time pressure, are reportedly very sensitive to HIV decline 
(Levine et al., 2008). These deficits are thought to have functional relevance e.g. 
in terms of the person’s ability to adhere to medication routines and carry out 
other tasks of independent living (e.g. Marcotte et al., 2006; Sorenson, Martin, & 
Robertson, 1994). 
 
Grant (2008) and Levine et al. (2008) note that assessments of attention are 
often timed, and are therefore closely connected to information processing 
speed. Further Woods et al. (2009) note that bradyphrenia (decline in processing 
speed) is evident on tests with (e.g. trail making tests) and without (e.g. the 
Stroop test) motor components. 
 
However a small number of studies exploring only information processing were 
found. For example Baldewicz et al. (2004) conducted a longitudinal study which 
explored cognitive functioning in 59 HIV positive participants in comparison to 55 
HIV negative participants; they found that HIV positive clients in different stages 
of the disease scored lower on tests of information processing than controls 
throughout the duration of the study. These findings suggest that tests of 
processing speed have good sensitivity to HAND.  
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Further, it has also been highlighted that processing speed and attention have a 
role in supporting higher order skills and that impairments in these skills can 
result in deficits in other cognitive domains (Hardy & Hinkin, 2002). 
 
1.9.3 Motor Skills 
A number of authors have commented that deficits in this cognitive domain are 
considered common in HAND and are reportedly a central feature of HIV-related 
cognitive deficits (Dawes et al., 2008; Rosca, Rosca, Chirileanu, & Simu, 2011). 
 
Robertson et al. (2007) have reported difficulties with slowed gait velocity and 
Carey et al. (2004) reported difficulties with the grooved pegboard task in 
individuals with HIV, a test of performance speed and fine motor skills. McArthur 
et al. (2010) point to impairments in rapid eye movements and frontal release 
signs. All authors commented that declines in performance are directly correlated 
with progression in disease. In line with this, a further study by Ogunrin and 
Odiase (2006) noted that performance in this domain was worse in participants 
with lower CD4 counts. 
 
Grant (2008) notes motor tests tend to be easy to administer in clinical settings, 
are thought to be culture free, and are therefore a useful tool in assessing 
impairment in this group. 
 
1.9.4 Visuo-Spatial Functions 
Heaton et al. (1995) and Woods et al. (2009) note that the occipital and parietal 
lobes, and therefore visuo-spatial perception, are not usually affected by HAND. 
However Sharma (2005) argues that connectivity of the basal ganglia (a key site 
of attack by the virus) to the dorsolateral prefrontal cortex, and posterior parietal 
lobes may result in parietal lobe dysfunction and consequently visuo-spatial 
dysfunction. Her study compared the performance of 20 HIV+ participants (at 
various disease stages) and 20 HIV- controls on tests of visuo-spatial perception. 
Performance on more complex tests indicated poorer map reading, spatial 
problem solving, and impaired constructional praxis in the HIV+ group. Sharma 
argues that these findings are indicative of impairment of the basal ganglia and 
parietal lobe connections, and consequently of spatial impairment in this group.  
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1.9.5 Language 
Language difficulties are not typically a central feature of the early stages of 
HAND, and if present (e.g. anomia or comprehension difficulties) are often 
indicative of additional comorbidity (e.g. Alzheimer’s disease; Backman, Jones, 
Agyuero-Torres, & Fratiglioni, 2003). However Grant (2008) notes that if an 
aspect of language is impaired, it tends to be performance on word generation 
tasks (i.e. complex skills such as fluency). In support of this Rippeth et al. (2004) 
reported that 40% of their sample with HAND displayed evidence of verbal 
fluency impairment – a skill associated with frontostriatal systems and executive 
functioning. 
 
1.9.6 Learning & Memory 
Grant (2008) defines working memory as the first stage of the remembering 
process, comprising temporary storage and manipulation of auditory, visual or 
other sensory information. It is highly dependent on attention and executive 
function skills. Martin et al. (2001) reported immediate ‘online’ memory 
manipulation impairments in those with HIV infection, and Farinpour et al. (2000) 
reported working memory deficits across visual and verbal modalities. Stout et al. 
(1995) reported finding difficulties even in asymptomatic seropositive participants. 
Further, Bassel, Rourke, Halman, and Smith (2002) reported that degree of 
working memory impairment is associated with subjective reports of memory 
complaints.    
 
New information moves from temporary storage in working memory to the next 
stage, which supports learning and remembering. Heaton et al. (1995) showed 
that 50% of their sample in varying stages of HIV disease demonstrated 
difficulties in learning different types of information, including explicit and 
procedural information. The authors also noted that those with HIV tend to score 
worse on tests of learning both verbal and non-verbal information in comparison 
to controls. Woods et al. (2009) and Grant (2008) note that tests of episodic 
memory (e.g. tests involving learning a story) and of list-learning are among the 
most sensitive to early HAND. 
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Murji et al. (2003) suggest difficulties in new learning are the result of faulty 
executive coding rather than a deficit of memory formation, and are similar to 
difficulties seen in other subcortical dementias (e.g. Parkinson’s Disease). 
Supporting evidence comes from Delis et al. (1995) who compared the 
performance of 18 HIV+ participants with controls on the California Verbal 
Learning Test, with results suggesting that the index group exhibited both 
encoding and retrieval deficits; the authors therefore concluded that a subcortical 
memory profile was present in this group. Further Peavy et al. (1994) note that 
free recall of verbal material is often lacking in strategic encoding techniques (e.g. 
semantic clustering), and Castelo, Sherman, Courtney, Melrose and Stern (2006) 
note that this is consistent with impairment to the frontostriatal loop of the brain.  
 
Literature on prospective memory (‘remembering to remember to do something’) 
is particularly useful to explore in this group given the importance of this skill in, 
for example, remembering to take medication.  This skill is often impaired as a 
result of problems with intention formation and difficulties in retrieval of future 
intentions (Carey, Woods, Rippeth, Heaton, & Grant, 2006). However Woods et 
al. (2009) note that prospective memory deficits are not often reported by this 
group, perhaps due to a lack of awareness of them. Rourke, Halman, and Bassel 
(1999) note that this lack of awareness may also be linked to executive function 
deficits, and that both are central to carrying out tasks of everyday living, 
engaging in social situations, engaging in occupation, etc. Consequently, 
prospective memory will be discussed below in the context of executive 
functioning (Section 1.8.7) 
 
Information that is in long-term storage is usually robust and resistant to decay, 
even in those with dementias such as Alzheimer’s disease unless the disease is 
well progressed. In line with this Manly et al. (2011) reported that the memory 
loss in their sample of individuals in the advanced stages of HAND was indicative 
of difficulties with retrieval. 
 
It is also worthy of note that a number of studies have reported on the impact of 
risk factors on memory in those with HIV. For example Heinz, Fogler, Newcomb, 
Trafton and Bonn-Miller (2014) report that their study found problematic alcohol 
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use impacted retrieval based aspects of memory functioning. A drawback of this 
study is that it utilised a self-report assessment of memory functioning – the 
Everyday Memory Questionnaire. However other studies have also reported 
memory difficulties in comorbid individuals with HIV and alcoholism e.g. Fama et 
al (2009) reported episodic memory impairments in their sample using the 
MicroCog computerised assessment tool. 
 
In addition to substance use, the literature base has also explored the impact of 
other risk factors that are thought to potentiate the impact of memory impairments 
in HIV. Seider et al (2014) conducted a longitudinal study which concluded that 
age and HIV interact to produce larger declines in verbal memory over time whilst 
Woods et al (2013) concluded poorer visuo-spatial temporal order memory 
deficits in older adults. 
 
1.9.7 Executive Functioning 
As note earlier, executive deficits are implicated in a range of neuropsychological 
presentations and there is strong consensus that impairment in this cognitive 
domain is a common and central feature of HAND (Dawes et al., 2008; Rosca et 
al., 2011).  
 
1.9.7.1 Executive Functioning Skills 
The term ‘executive functioning’ encapsulates a number of complex higher-order 
skills including mental flexibility, abstract reasoning, initiation, planning, decision-
making, set-shifting (holding a number of tasks in mind), social behaviour, affect 
and motivation (Hodges, 2007). Burgess and Alderman (2012) note that the term 
refers to cognitive abilities that enable a person to determine goals and formulate 
new and useful ways of achieving them. They enable people to effectively resolve 
the challenges they encounter in everyday life, and cope with new situations 
(Burgess & Simons, 2005). Duncan and Owen (2000) highlight their centrality to 
everyday life by explaining that some executive functions are required in many 
situations (e.g. attention and arousal) whilst others are only required in particular 
circumstances (e.g. multitasking). 
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Hodges (2007) notes that executive functions support behaviour to be 
appropriate and modifiable and those with frontal lobe damage show impairments 
in these abilities e.g. they may demonstrate poor planning and failure to cope 
with changes. 
 
There are a number of studies exploring different types of executive function. 
Grant et al. (1987) note that subtle disturbances in abstraction can be detected 
using the Halstead Category test in those who are medically asymptomatic, 
though deficits are more strongly present in latter stages of the disease. 
Difficulties have also been reported with set shifting/switching when assessed 
with the Wisconsin Card Sorting test (Carter et al., 2003), and with the Trails B 
test (Heaton et al., 1995). Response inhibition problems have been found using 
the Stroop color word test (Tozzi et al., 1999) and also in decision-making (as 
reported by Martin et al., 2004). Further, Tate et al (2011) highlight the 
importance of recent clinical history (CD4 counts obtained in the last twelve 
months) on performance in particular tests of executive functioning (e.g. a 
computerised tests of switching and verbal inhibition).   
 
Moradi, Miraghaei, Parhon, Jabbari, and Jobson (2013) conducted a recent study 
in Tehran comparing thirty-four individuals with HIV to locally-matched healthy 
controls on measures of executive function and autobiographical memory, 
arguing that retrieval of specific memories is cognitively effortful and can be 
impaired in those with executive dysfunction. They reported lower performances 
on the Wisconsin Card Sorting test and the Tower of London test in the index 
group (in addition to poorer performances on tests of autobiographical retrieval). 
There are a number of strengths of this study including the use of culturally 
normed measures and, as mentioned, the use of a control group that was 
matched not only culturally but also geographically. However the study may lack 
generalizability since the sample was small, and the control group was self-
selected. Further the authors used ‘duration of having HIV’ as a variable; it may 
be argued that it is difficult to know exactly when an individual acquired HIV. 
Consequently individuals often harbour the virus for indeterminate periods of time 
without knowing they are infected or presenting with any symptoms. 
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Consequently it is unsurprising that this variable did not prove to be correlated 
with other variables in this study (i.e. executive and autobiographical measures).         
 
Exploration of prospective memory (remembering to remember), was briefly 
explored in section 1.9.2, but is particularly relevant to this discussion since Doyle 
et al (2013) note that the cognitive architecture of this skill is heavily dependent 
on frontostriatal systems and executive functioning. Time based prospective 
memory (the neurocognitive capacity to remember to undertake a task at a 
particular moment in the future) is particularly important for maintaining 
independence and, as argued earlier, plays a key role in medication adherence 
(Contardo, Black, Baeuvais, Dieckhaus & Rosen, 2009). Doyle et al.’s study 
explored this skill in fifty-five individuals with HAND and a comparison group 
using the Memory for Intentions Screening Test. Their study found that those with 
HIV demonstrated poorer clock-checking rates than the control group. However, 
a number of compounding factors may have impacted the findings of this study. 
Firstly, there appeared to be higher rates of anxiety and depression in the HAND 
group than in the control group as measured by the Profile of Mood States 
(McNair, Lorr, & Droppleman, 1981).  Secondly, the study may have limited 
ecological validity since those with CNS opportunistic infections were excluded 
from participating in the study and Heaton et al (2011) have argued that only 7-
10% of the HAND population do not present with these infections. This may limit 
the generalizability of Doyle et al.’s study. However, an interesting conclusion of 
the study is that time based prospective memory was found to be positively 
correlated with performance on a test of verbal fluency, thus indicating that both 
are dependent on cognitive flexibility and self-monitoring.  
 
Sahakian et al. (1995) conducted a study with HIV+ male patients using a test of 
spatial working memory, the Tower of London test (which assesses higher-level 
planning ability), and an attentional set-shifting test (the Wisconsin Card Sorting 
Test). HIV+ participants were more likely to be impaired in all three tests of 
executive function in comparison to controls. However a number of criticisms may 
be made about the study. Firstly, since only male participants were assessed for 
this study, the generalizability of the findings may be limited particularly since 
section 1.5.1 highlighted evidence to suggest that profiles of impairment may 
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differ between males and females. Secondly, the authors, though passing 
comment, did not systematically document how performance on the three tests 
varied in relation to each other. Further, the authors failed to highlight that they 
only assessed particular types of executive function skills however their 
conclusions implied ‘global’ executive function deficits in this group. This is not a 
criticism unique to this study, and literature searches failed to find research 
exploring how a range of executive functions varied in relation to each other. 
Additionally, as demonstrated in the literature review above, studies often use a 
range of measures of executive functioning, and explore different types of 
executive skills, thus making it difficult to synthesize the evidence. Consequently 
there is a gap in the literature base exploring the profile of executive function 
deficits in HAND.  
 
1.9.7.2 Theoretical Foundations of Executive Functioning 
Executive functions are thought to be supported by the frontal lobes of the brain. 
Hodges (2007) notes that this area is the ‘chief executive officer’ of intellectual 
functioning and is connected to, and orchestrates, virtually all other cortical and 
subcortical structures. Consequently damage to this area can have widely 
dispersed effects on cognition. However as noted above, Ellis et al. (2007) 
indicate this is an area, alongside the basal ganglia, and the posterior parietal 
cortex, that is often targeted by the neurotoxic and neurodegenerative processes 
inflicted by HIV. Damage can result in devastating effects on an individual’s ability 
to maintain independence (Cattie et al., 2012).  
 
A number of theories have explored how the executive function system supports 
development of, and adaptation to, new ways of behaving. Burgess and 
Alderman (2012) note that although theories frequently change, some theories, or 
aspects of theories, have stood the test of time and one such theory is described 
by Norman and Shallice (1986). This perspective states that behaviour is 
determined by thought or action schemas (sets of actions or cognitions closely 
associated through practice). Schemas can be triggered by routine events in the 
environment since there are well-learned links between environmental stimuli and 
our responses to them (e.g. whilst driving and stopping at a pedestrian crossing). 
However Shallice (1988) noted that in novel situations, or where well-learned 
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responses are no longer useful and need to be inhibited, another system (the 
supervisory attentional system) is required to modify schema activity. Here, 
impairment of the supervisory system will result in the continual selection of the 
previously useful schema and result in behavioural inflexibility. The authors also 
noted that it may be the case that when the focal activity is not linked to 
environmental cues, a deficit in the supervisory system may lead striking 
environmental cues to provide excessive attention distractibility. Hence Burgess 
and Alderman (2012) conclude that dysfunction of the supervisory system may 
explain two resultant outcomes following frontal lobe damage – excessive rigidity 
and excessive distractibility. 
 
1.9.7.3 Executive Function Assessment 
Later revisions of Shalice’s theory have noted that different areas of the prefrontal 
cortex are connected internally with each other, and externally with other brain 
structures; thus the interconnected nature of all brain structures make simple 
function-to-structure localisation improbable. Therefore Burgess and Alderman 
(2012) conclude that selecting tests on the basis of the impaired brain regions 
would not be clinically helpful.  
 
However the authors note that some guidelines are available for selecting tests of 
executive function given what is already known about dysexecutive syndromes 
and what theoretical approaches tell us. Consequently Burgess, Alderman, 
Evans, Emslie, and Wilson (1998) highlight that tests of executive function should 
at the least include assessments of inhibition, measures of executive (short 
term/working) memory ability, and tests of multitasking.  
 
Given our discussion above about the impact of damage in one area leading to 
impairment of functionality in other parts of the brain, any research exploring 
executive function would need to include a core composite battery. This would 
allow assessment of strengths and weaknesses in particular cognitive domains. 
 
1.9.7.4 The Role of Executive Functioning in Maintaining Independence 
HAND is often coupled with diverse psychological, cognitive, and medical 
consequences which can impact independence and the ability to fulfil activities of 
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daily living. Woods et al. (2009) report that as many as 50% of those with HAND 
will have some degree of functional impairment. Further, Vance, Fazeki and 
Gakumo (2013) note that complex tasks are likely to be impaired in earlier stages 
of disease (e.g. cooking) and simpler tasks (e.g. dressing) later. 
 
Chaytor (2005) highlight the importance of considering the relationship between 
neuropsychological assessment and ‘real world’ functioning ability.  
Heaton et al. (2004) reported difficulties in executive functioning have been found 
to be strongly linked with a decline in everyday functioning and Ellis et al. (2007) 
highlight that people with HAND are more likely to be unemployed and have 
poorer medication management skills. Marcotte et al. (2006) have written about 
the impact of HAND on the ability to drive. 
 
Consequently the importance of executive functioning skills in the maintenance of 
independence becomes clear when we consider, for example, the impact of 
slower information processing speed and inattention (e.g. on the ability to use 
information in decision-making processes), and switching difficulties (e.g. on the 
ability to switch between competing demands). 
 
 
1.10 Justification 
 
As noted above the advent of cART has changed the classification of HIV from a 
fatal condition to a chronic lifelong condition. However HIV and cART can cause 
neuropathological and neurotoxic damage to the central nervous system, and 
thus result in HAND. Since cART is supporting people to live longer, the 
prevalence of HAND is predicted to increase.  
 
Executive function deficits are a key feature of HAND, and are often linked to 
impairments in activities of independent living. However assessment screens 
used in clinical settings are often insensitive to early impairment and this may 
have implications on obtaining appropriate care and support. Further, since it is 
not always possible to assess multiple types of executive function in clinical 
settings it is important to explore whether particular executive function skills are 
Page 35 of 183 
more susceptible to decline than others i.e. it would be useful to know whether 
HIV is paired with a particular profile of executive function deficits. A critique of 
the current literature base is that there are currently no studies exploring this. A 
further critique is that when individual executive function abilities are explored 
(e.g. abstraction), the findings are generalised to suggest ‘global’ impairment 
across all other executive functions, and this may not be the case.  
 
1.11 Aims & Research Questions 
 
The aim of this study is to explore whether specific subdomains of executive 
functioning are affected (whilst others relatively preserved), or whether they are 
globally impaired. Consequently the study will explore the neuropsychological 
profile of executive function deficits in HAND. 
 
It may also be the case (as often reported in studies of executive deficits) that 
impairments are highly idiopathic, with some patients affected in some domains 
and not in others. Further, there is little guidance in the literature for the clinician 
on which executive function tests to choose. The current study will attempt to 
explore these issues in a typical sample of HAND patients. Taking account of the 
variability in the sample, the ‘group’ level of the analysis will be supported and 
informed by a case series approach to identify and respect differences between 
presenting profiles.     
 
The research question is as follows: 
 
“What is the executive function profile of HAND?” 
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2. METHOD 
 
 
2.1 Epistemology 
 
Although a full description of the debates and developments in epistemological 
thinking is beyond the scope of this section, a brief summary will usefully set the 
context for the philosophical position taken by the researcher.  
 
Barker, Pistrang, and Elliott (2003) note it is important for researchers to be 
aware of, and acknowledge, the philosophical context and assumptions under 
which their data is obtained. This awareness will guide, to a degree, coherent and 
informed choices about methodological designs, and the conclusions that can be 
drawn from a particular study. Godfrey-Smith (2000) notes that the discipline of 
epistemology is concerned with such philosophical questions about knowledge; it 
explores where knowledge comes from, how it is acquired, and how we know or 
believe things to be true. 
 
Seventeenth and eighteenth century philosophers (e.g. Locke, Hume) argued 
that our senses (e.g. sight) are the single true source of knowledge about the 
world, and that ‘truth’ could only be obtained empirically by scientific methods. 
This perspective became known as Positivism, and it underpins the belief that it 
is possible to observe and describe phenomena objectively in a ‘theory-neutral’ 
way, for the purposes of prediction and control. 
 
A shift in thinking was influenced by theorists such as Hanson, Kuhn, and 
Feyerabend who argued that the perspective of the observer influences what is 
perceived. This difference in opinions has been articulated via the theory-
ladenness of observation debate (Godfrey-Smith, 2000). Godfrey-Smith 
summarises the key issues as follows: 
“…can observational evidence be considered an unbiased and neutral  
source of information … or do observations tend to be ‘contaminated’ by 
theoretical assumptions in a way that prevents them from having this 
role…” (p. 155)   
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This questioning of neutrality became the foundation of various more critical, 
post-positivist views, and Willig (2008) notes is it now generally accepted by most 
perspectives that observation is selective.  
 
One such perspective, critical realism, argues that although there is a reality that 
exists it cannot be completely known, as observation is a process influenced by 
human error and biases (Trochim, 2000).  
 
In spite of the research questions lending themselves to more positivist 
epistemologies, the critical realist approach was adopted by the researcher of this 
study due to the critiques of writers such as Sontag (1991; briefly explored in the 
introduction). These critiques highlight the social construction of diseases such as 
HIV and their associated impairments. They lead us to be mindful that 
neuropsychological domains – and indeed executive functions – are also 
constructs subject to refinement and change. Hence although empiricist methods 
are being used to obtain the data, the author retains a critical awareness of the 
constructs under study, and of the possible impact of personal perspectives on 
what is found. 
 
 
2.2 Participants 
 
2.2.1 Recruitment 
Participants for the study were recruited from a charitable multidisciplinary 
neurorehabilitation hospital based in London. The hospital provides specialist 
care for people with HAND. It has 16 inpatient beds and provides day services for 
a further 60 people. 
 
2.2.2 Eligibility for Inclusion 
Individuals are referred to the hospital with a wide variety of psychological and 
medical conditions. Consequently core inclusion and exclusion criteria were 
developed at the start of the study.  
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Core inclusion criteria required that participants had a diagnosis of HIV, some 
symptoms indicative of HAND, were English speakers, and that they were over 
the age of 18. Further criteria are explored in the sections below.  
However the list only served as a guide, and the site consultant and clinical 
psychologist assessed suitability of patients for inclusion on a case-by-case 
basis. Their decisions were made on the perceived/hypothesised impact of 
untreated medical (e.g. infections) and psychological (e.g. active 
psychosis/depression/anxiety) comorbidities on cognitive functioning. 
 
2.2.2.1 Medical Comorbidities 
Following discussions with the consultant physician, and after screening referrals 
made to the inpatient unit, it was noted that syphilis, meningitis (crytococcal and 
tuberculous), and toxoplasmosis are frequently seen comorbid infections and can 
cause, amongst other things, confusion, cognitive decline, and memory loss. 
However it was agreed that people presenting with these infections would be 
invited to participate in the study after their conditions were treated. This was also 
the case for those presenting with urinary tract infections and other inter-current 
acute infections.  
 
However those with progressive multifocal leuoencephalopathy (PML), which is 
thought to result in irreversible clumsiness, aphasia and memory loss were not 
recruited. Further, those with Hepatitis (B and C) were also excluded due the 
impact of the disease on global cognitive performance. CNS tumours and lesions 
are commonly seen in inpatients presenting at the unit and can have various 
effects on cognition depending on their location. Consequently participants with 
present tumours and lesions were not invited to participate in the study.   
 
Participants with a history of substance use were invited to participate unless 
there was clear evidence of any misuse-associated brain damage (e.g. Wernicke- 
Korsakoffs disease). 
 
2.2.2.2 Psychological Comorbidities 
As noted in the introduction, there are reportedly high rates of anxiety and 
depression in HIV patients. Depression has been linked to low levels of 
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motivation, and anxiety to off task activity and distraction. Due the high levels of 
prevalence it was decided to include participants with mild and treated forms.  
 
Less frequently, clients with active psychosis (or a history of psychosis) also 
attend the unit; it was decided that these service users would be invited to 
participate if their symptoms were not currently active. Those presenting with 
other psychological difficulties were assessed for inclusion on a case-by-case 
basis. 
 
2.2.2.3 Learning Disabilities 
During the recruitment phase of the study, no patients with learning disabilities 
were admitted to the unit. However it was decided that those presenting with 
learning disabilities would not be included in the study due to the likely impact of 
their disabilities on test performance. 
 
2.2.2.4 English Facility 
Although level of spoken English did not effect access to routine 
neuropsychological assessments, only those who were fluent English speakers 
were invited to partake in the study due to the inherent bias of 
neuropsychological measures against those who do not have good command of 
the English language. 
 
2.2.2.5 Consent 
Only patients who were independently able to consider taking part in the study 
and provide consent were recruited. 
 
2.2.3 Recruitment Procedure 
Participants were only recruited from the inpatient unit of the hospital as this 
allowed easier access to information about current health status and, therefore, 
informed choices about who would be suitable for the study.  
 
Neuropsychological assessment is offered to all inpatients as part of the standard 
assessment and treatment protocol, and is carried out by either the researcher (in 
my capacity as a trainee clinical psychologist) or the site clinical psychologist. All 
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referrals to the unit are screened by the hospital consultant and the clinical 
psychologist, thus allowing them to identify potential participants for the study.  
 
When a patient was deemed suitable for neuropsychological assessment, they 
were approached and provided with an explanation about (routine) 
neuropsychological assessment processes, information about how long the 
standard assessment was expected to take (1.5 hours approximately), and 
information about how the results may be used to inform clinical care.  
 
The patient was then also informed about the study and the additional testing 
time (approximately 45 minutes), provided with an information sheet, a consent 
form, and answers to any questions they had. (Please see Appendices B-D for 
UEL Ethics Committee documentation, approved Participant Information sheet, 
and Consent Form). Participants were also assured that their choice to partake in 
the study had no bearing on the clinical care they would receive. 
 
2.2.4 Participant Characteristics 
16 participants were assessed for the study. Participant characteristics are shown 
in Appendix E. There were 6 females and 10 males. Their ages ranged between 
23 and 72 years (mean 49.25). Six were born in the UK (1 British Asian, 2 Black 
British, 3 White British) and one participant was born in the USA (White). All of 
these participants had English as their first language. One participant was 
Portuguese (though born in the Congo). One participant was Congolese, one 
Ghanaian, one Kenyan, one Nigerian, one St Lucian and one Zimbabwean. Two 
participants were Ugandan.  
 
Referring clinicians assessed level of English facility in those who were not 
primary English speakers to determine suitability of candidates for the study. The 
mean number of years of education in the sample was 10.94 and the range 4 – 
17 years. Four Participants had tuberculosis in the past and three participants 
had toxoplasmosis. Four participants had histories of psychiatric difficulties and 
one of substance misuse.  
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Eight candidates who were deemed suitable for the study declined assessment 
for both clinical and study purposes. 6 candidates consented to 
neuropsychological assessment for clinical purposes but declined inclusion of 
their data in the study. Consequently these candidates were only administered 
the core (service) battery. 
 
 
2.3 Design 
 
As this was an exploratory study, a cross section correlational research design 
was employed to investigate possible relationships.  
 
Sample size was guided by numbers utilised by other exploratory studies of 
subcortical dementias (e.g. Abrahams et al, 2000). Although a power calculation 
was considered, it was decided it might not be helpful in this case since the aim 
of the study was to measure size of effect, and this is relatively independent of 
sample size (Clark-Carter, 1999). However, since a study is considered more 
powerful if the number of participants is greater, attempts to obtain as large a 
sample as possible were made given time, resource, and referral rate constraints. 
 
2.3.1 Testing Materials 
A battery assessing premorbid functioning, current cognitive status, and 
executive functioning was utilised. 
 
2.3.1.1 Assessment of Premorbid Functioning 
The Weschler Test of Adult Reading (Weschler, 2001) was used since the ability 
to read irregular words is usually resistant to cognitive decline until latter stages 
of disease (Strauss, Sherman, & Spreen, 2006). Normative data was obtained 
from a representative sample of 1134 American participants and 331 British 
participants (as determined by census data) and is published in the test manual.   
The manual reports that an equal number of males and females were recruited in 
the American sample between the ages of 16-64, however the older age groups 
included more women. The UK sample also included more females and males.  
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Participants are presented with a list of 50 irregular words and asked to correctly 
pronounce them aloud. None of the words have phonemic pronunciations, thus 
minimising the participant’s ability to say the word based on previously learned 
rules; the participant is therefore forced to rely solely on previously learned 
pronunciations/knowledge of the word. Consequently it is thought to have good 
clinical utility in assessing level of cognitive ability before onset of disease or 
injury. The numbers of words correctly pronounced are compared to normative 
data to provide scaled scores, percentile ranks, and indices of function. 
 
The test also provided a measure of fluency in English (although no participant 
was excluded for achieving low scores on this measure, and their facility to speak 
and understand English was assessed by referring clinicians before being 
approached by the researcher). 
 
2.3.1.2 Assessment of Current Functioning 
The Repeatable Battery for the Assessment of Neuropsychological status 
(RBANS; Randolph, 1998) was used to assess current neurocognitive 
deficits/status. Normative data is based on a sample of 540 American participants 
between the ages of 18 to 89, and is published in the test manual. Information on 
the gender of participants is not provided, however data on ethnicity is included: 
81% of the sample were White American, 13% African Americans, and 7% 
Hispanic Americans.  
 
Although there are a plethora of batteries available, the RBANS was chosen for a 
number of reasons. Firstly, the battery is used by the service and employing it in 
the study meant that there would be no differences to the clinical care of patients 
who did not participate in the study. Secondly, it covers areas associated with 
HIV cognitive impairment, but also allows consideration of other profiles (e.g. it 
can also identify profiles indicative of other diseases and syndromes such as 
Alzheimer’s disease). 
 
Further, the battery was selected due to its reported reliability and utility when 
working with neurologic injury or disease (Hodges, 2007). It is brief to administer 
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(taking approximately 30-45 minutes), and is suitable for use at the patient’s 
bedside (Lezak, Howieson, & Lorig, 2004). 
 
An additional benefit to using the RBANS is that it is a comprehensive battery 
assessing different cognitive abilities. Individual tests in comprehensive batteries 
are co-normed, thus allowing easier comparisons between tests; this method is 
preferable to using subtests from different composite batteries. 
 
The battery assesses function of five cognitive domains through performances on 
thirteen subtests (see Table 2.3-1). 
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Table 2.3-1 RBANS subtests 
Cognitive 
Domain 
Subtest Test Description 
Attention 
Forward Digit 
Span 
Participants are asked to repeat strings of numbers, 
which increase in length as the test progresses.  
Coding 
Participants are presented with a sheet of paper which 
has a printed key pairing the numbers 1 to 9 with 
nonsense symbols. Underneath the key are rows of 
symbols and empty boxes and participants are asked 
to fill in the boxes with the number that is paired to the 
symbol in the key above. Participants are given 90 
seconds to complete this task.  
Immediate 
Memory 
List Learning 
Participants are verbally presented with a list of 10 
unrelated words and asked to immediately repeat as 
many as they can remember, across four trials.  
Story Learning 
Participants are verbally presented with a 12-item short 
story and asked to repeat as many details as they can 
remember, across two trials.  
Visuospatial 
Figure Copy 
 
Participants are asked to directly copy a complex 
drawing comprising 10 components.  
Line Orientation 
 
Participants are presented with a drawing consisting of 
13 lines fanning 180 degrees from a single point. 
Underneath this figure, ten target items are presented 
consisting of two target lines, and participants are 
asked to identify which lines the target matches from 
the figure. 
Delayed 
Memory 
List Recall After a 20-minute delay, participants are asked to recall words that were presented in the list learning subtest. 
List Recognition 
Participants are presented with a list of twenty words – 
ten of which are from the List Learning subtest, and ten 
that are distractor items. Participants are asked the 
identify the words that were part of the List Learning 
subtest. 
Story Recall 
After a 20-minute delay, participants are asked to recall 
as many details as possible about the story presented 
in the Story Learning subtest.  
Story Recognition 
Participants are asked to answer 10 yes/no questions 
about the story they learned for the Story Learning 
Subtest. 
Figure Recall Participants are required to redraw the figure they copied for the Figure Copy test after a 30 minute delay. 
Language 
Picture Naming 
 
Participants are presented with line drawings of 10 
objects that they must name.  
Semantic Fluency Participants are given a semantic category and asked to name as many exemplars as possible in 60 seconds. 
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2.3.1.3 Assessment of Executive Function 
A number of authors have detailed skills that should be assessed by executive 
function batteries (see Burgess & Alderman, 2012, and Burgess et al., 1998). 
These include verbal fluency, sequencing, inhibition, working memory, and rule 
deduction. The test set was designed with these recommendations in mind. 
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Table 2.3-2 Executive Function Assessment Battery 
 Function Tests 
1 Word generation - verbal 
fluency 
Verbal Fluency –  DKEFS (Delis, Kaplan, & 
Kramer, 2001). 
2 Word generation – category 
fluency  
Semantic Fluency – DKEFS (Delis et al., 2001) 
3 Switching Verbal Switching – DKEFS (Delis et al., 2001) 
4 Verbal working memory Digit span forwards – WMS-III (Wechsler, 1997) 
Digit span backwards – WMS-III (Wechsler, 
1997) 
5 Verbal initiation  Hayling Test, Sentence Completion 1 (Burgess & 
Shallice, 1997) 
6 Verbal inhibition Hayling Test, Sentence Completion 2 (Burgess & 
Shallice, 1997) 
7 Visual sequencing Trails A (Reitan, 1992) 
8 Visual switching  Trails B (Reitan, 1992) 
9 Visual working memory Spatial span, Kaplan Baycrest Neurocognitive 
Assessment (KBNA; Leach, Rewilak, Richards, & 
Proulx, 2000) 
10 Rule deduction Brixton Test (Burgess & Shallice, 1997) 
11 Processing Speed & attention  Verbal production test, based on Simple 
recitation – WMS-III Mental Control, items 1-4, 
(Wechsler, 1997) 
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1. Word Generation/Letter Fluency 
Verbal Fluency test – DKEFS (Delis et al., 2001). This test allows assessment of 
word generation skills.  Participants are given a specific letter (‘F’, ‘A’, and ‘S’) 
and asked to give as many words as possible beginning with that letter in one 
minute. Normative data is provided in the DKEFS test manual, and is based on 
1750 American participants aged between 8-89. The normative sample was 
based on equal number of males and females in the younger age groups, though 
more females in the older age groups. The ethnicity of the sample was 
considered representative of the American population.   
 
2. Word Generation/Category Fluency 
Semantic Fluency test – DKEFS (Delis et al., 2001). This test allows assessment 
of semantic retrieval strategies. Participants are given categories (‘animals’ and 
‘boys names’) and asked to provide as many exemplars as possible in one 
minute. Normative data is provided in the DKEFS test manual, and is based on 
1750 American participants aged between 8-89. The normative sample was 
based on equal number of males and females in the younger age groups, though 
more females in the older age groups. The ethnicity of the sample was 
considered representative of the American population.   
 
3. Switching 
Switching - DKEFS (Delis et al., 2001). Participants are given two categories 
(‘fruit’ and ‘furniture’) and asked to switch between them, providing self-generated 
exemplars from each in turn, as many times as possible within one minute.    
Normative data is provided in the DKEFS test manual, and is based on 1750 
American participants aged between 8-89. The normative sample was based on 
equal number of males and females in the younger age groups, though more 
females in the older age groups. The ethnicity of the sample was considered 
representative of the American population.   
 
4. Verbal Working Memory 
a. Digit span forwards WMS-III (Wechsler, 1997) Participants are asked to 
repeat strings of numbers increasing in length.  
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b. Digit span backwards – WMS-III (Wechsler, 1997). Participants are asked to 
repeats strings of numbers increasing in length, in reverse order. This test 
allows assessment of participants’ ability to temporarily hold and manipulate 
information.  
  
Normative data was obtained from 1250 American participants aged between 16-
89 and is published in the test manuals. 
 
5. Verbal Initiation 
 Hayling Test 1 – Sentence Completion (Burgess & Shallice, 1997). This test 
allows for assessment of response initiation and processing speed.  Here 
participants are presented with 15 sentences and asked to provide a word which 
completes the sentence, as quickly as possible. Normative data was obtained on 
118 British participants aged between 18-80 and is published in the test manuals.  
61 participants were females and 57 males. Race/ethnicity data was not reported. 
 
6.  Verbal Inhibition 
Hayling Test 2 – Sentence Completion (Burgess & Shallice, 1997). This test 
allows for the assessment of response suppression and thinking speed. 
Participants are presented with 15 sentences with a word missing at the end and 
are asked to provide a nonsensical word to complete the sentence, one that is 
unconnected to the sentence in every way. Normative data was obtained on 118 
British participants aged between 18-80. 61 participants were females and 57 
males. Race/ethnicity data was not reported.  
 
7. Visual Sequencing 
Trails A (Reitan, 1992). This test allows assessment of visual sequencing 
without alternation and is timed, thus allowing for assessment of visual 
processing speed. Participants are presented with a sheet containing numbers 
from 1 to 25 scattered across a page, and are asked to connect them 
sequentially as quickly as possible. Normative data is provided by Davies (1968) 
based on 540 British participants, and is provided in the test manual. 
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8. Visual Switching 
Trails B (Reitan, 1992). This test allows assessment of visual sequencing and 
alternation. Participants are presented with a sheet of paper with circles 
containing both numbers (1 to 13) and letters (A to L) scattered randomly. The 
participant must join the circles sequentially in ascending order, whilst alternating 
between numbers and letters (i.e. 1-A-2-B-3-C and so forth). This is a timed task. 
Normative data is provided by Davies (1968) based on 540 British participants, 
and is provided in the test manual. 
 
9. Visual Working Memory 
Spatial span, KBNA (Leach et al., 2000). This test allows assessment of visuo-
spatial short-term memory. The participant is presented with a sheet of paper 
with randomly scattered dots. The researcher touches particular dots and the 
participant is asked to touch the same items, in the same order. Normative data 
was obtained from 700 American participants aged between 20 – 89 years and is 
provided in the test manual. 78% of the sample were White Americans, and 53% 
females.  
 
10. Rule Deduction  
Brixton Test (Burgess & Shallice, 1997). This test allows for the assessment of 
visuospatial concept formation/rule deduction. Participants are presented with 56 
cards, each with ten circles. One of the circles is coloured and the participant is 
required to determine which of the circles will be coloured on the following card, 
based on the position of the coloured circle on preceding cards.  Normative data 
was obtained on 118 British participants aged between 18-80. 61 participants 
were females and 57 males. Race/ethnicity data was not reported. 
 
11. Processing Speed/Attention  
Verbal Production test. This test is based on the Simple Recitation test (WMS III; 
Wechsler, 1997) and involves speeded verbal output of rote sequences (e.g. 
months of the year). Norms have recently been established by Blupert (2014) and 
are based on 60 British primary English language speakers (32 females and 28 
males). 
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2.4 Analysis 
Raw scores from each test were converted into age-scaled scores (with a 
common mean value of 10 and a standard deviation of 3), derived from published 
norms in test manuals and research literature as noted above (please see 
Appendix F for ranges and subjective labels based on Slick, 2006). 
 
Correlational analyses were used to explore possible relationships between tests. 
 
Additionally, patterns within individual profiles were explored with case controlled 
analyses. 
 
 
2.5 Procedure 
Participants were tested alone, usually in their rooms (ward staff were always 
made aware of the assessment). A brief outline of the assessment process was 
again given to the participant, including further discussion of the study information 
sheet and consent form if requested. It was made clear to participants which tests 
were part of the routine neuropsychological assessment protocol and which were 
part of the executive skill battery (i.e. the additional research component). 
 
Participants were informed that they would receive a 30-minute break midway 
through the assessment to prevent motivation being negatively impacted by 
fatigue and boredom. They were also offered the opportunity to split the 
assessment across two test dates if they preferred and were reminded of this 
throughout, as recommended by the UEL Ethics Committee. However this was 
not taken up by any of the participants. 
 
A brief initial assessment was conducted with each participant to ascertain 
number of years in education, occupational status, ability to speak English, and 
any other factors that may impact performance on the assessment (e.g. mood, 
ability to hear, etc.).  With permission, information on latest CD4 counts and viral 
load was also collected from medical notes to allow examination of the 
relationship between disease severity and test scores. 
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Following this the battery was administered; the WTAR was administered first, 
followed by the RBANS, and then the executive function tests. A break would be 
offered after the RBANS to ensure that an appropriate amount of time had lapsed 
between the immediate recall and delayed recall tasks.  
 
After assessment participants were offered verbal debriefing, and were informed 
that they would receive feedback and a brief written report approximately one 
week later. This would include a summary of their strengths and weaknesses, 
and also some compensatory strategies if applicable. They were also made 
aware that, with their consent, a full report would be sent to the team consultant, 
the HIV consultant, and the HIV clinical nurse specialist for the purposes of 
informing future care. 
 
 
2.6 Ethics 
Ethical approval was sought from the University of East London Ethics 
Committee.  Before providing approval the committee asked for minor 
amendments. These included adding tick boxes alongside each statement in the 
consent form, ensuring participants received feedback following their 
assessments, and, as mentioned, offering assessment over two appointments. 
These amendments were accommodated into the research protocol. 
2.6.1 Obtaining Fully Informed Consent 
The study recruited participants who were assessed by the consultant and the 
clinical psychologist as being able to consider participation and provide consent. 
 
Identified candidates were approached and informed about the study when 
discussing an appointment for routine clinical assessment. They were allowed up 
to a week to consider participation. If they agreed, their decision was discussed 
again in more detail at the start of the assessment in order to ensure adequate 
time to raise any questions or concerns. They were then asked to sign a consent 
form. 
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2.6.2 Right of Withdrawal 
The right to withdraw from the study was highlighted to each participant with the 
assurance that this would not impact his or her clinical care. This was also 
explained in the participant information leaflet.  
 
2.6.3 Anonymity & Confidentiality 
Because of the nature of the study, data was not gathered anonymously. To 
protect confidentiality, participant data sheets were assigned numbers for 
identification purposes. Thereafter numbers (instead of names) were entered into 
record databases and statistical programmes used in the analysis. Further, any 
participants discussed in the final report were referred to by their participant 
numbers, thus ensuring confidentiality. 
 
Completed test sheets were stored in locked NHS filing cabinets, in accordance 
with the Data Protection Act (UK Parliament, 1998) for 5 years. 
 
2.6.4 Protection of Participants 
Participants were continuously monitored for signs of fatigue and distress during 
testing, and breaks were offered as appropriate. Verbal debrief at the end of 
testing was provided to participants and, with their consent, a report sent for the 
unit consultant, their HIV consultant, and their clinical nurse specialist for the 
purposes of informing appropriate care. 
 
2.6.5 Protection of the Researcher 
No risks to the researcher were identified at the start of the project and this held 
true throughout collection of data. However it was agreed at the start of the study 
that should any issues arise, these would be discussed with the allocated 
Director of Studies, and if appropriate, senior clinicians at the Hospital. 
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3. RESULTS 
 
 
3.1 Exploration of Participant Data 
 
Field (2011) notes that the first stage of analysis involves obtaining measures of 
central tendency, in addition to measures of spread and shape. These processes 
allow exploration of the data for errors and outliers, and to determine whether it 
conforms to the assumptions necessary for parametric examination.   
 
Table 3.1-1 shows that age, education, and WTAR scores were principally 
normally distributed (Skewness <1, Kurtosis <3, and Shapiro Wilk Significance 
>1; Field 2011). In terms of measures of variability, all had large standard 
deviations. 
 
A larger proportion of CD4 counts in the sample were low thus (slightly) positively 
skewing the data. However the Kurtosis statistic suggests that this data was 
normally distributed (Kurtosis <3). Viral load scores in the sample were also 
positively skewed, and required thresholds were not reached in the Kurtosis and 
Shapiro-Wilk analyses thus suggesting non-normal distributions in this sample.  
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Table 3.1-1 Descriptive Statistics & Analyses of Distribution for Participant 
Characteristics  
 Min Max Mean SD Skewness 
(SE:0.564)  
Kurtosis 
(SE:1.091) 
Shapiro-
Wilk 
(Sig) 
Age (yrs) 23 72 49.25 12.668 -.486 .753 .442 
Education 
(yrs) 
4 17 10.94 4.024 -.109 -.460 .397 
WTAR 3 15 9.27 3.826 -.271 -.838 .517 
CD4 2 991 233.25 278.450 1.696 2.685 .002 
VL 0 100000000 6653022.13 24905931.812 3.993 15.958 .000 
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3.2 Exploration of Test Data 
 
Test data (in the form of scaled scores) was also analyzed to establish 
descriptive statistics and distribution characteristics. 
 
The Kurtosis analysis in Table 3.2-1 demonstrates that the data mainly had 
platykurtic frequency distributions (i.e. broader, flatter distributions that are 
considered non-normal; Clark-Carter, 1999). Further, positively skewed 
distributions were observed on coding, and negatively skewed distributions on 
figure copy and picture naming.  
 
Other variables were not skewed. However Shapiro-Wilk values indicated that the 
data deviated from the normal distribution. Consequently analyses with 
parametric tests were not undertaken.  
 
Mean scores suggest that in this sample, performances on many tests (digit span 
forwards, digit span backwards, figure copy, picture naming, delayed list recall, 
delayed figure recall, letter fluency, and spatial span) fell within the average 
ranges (Figure 3.2-1 and Table 3.2-1).  However the standard deviations were 
large (Table 3.2-1), indicating wide variability within the scores for each subtest. 
Group level means also indicated that coding, list learning, list recognition, 
Brixton, Hayling 1, Hayling 2, and Trails A were within the impaired and below 
normal ranges. Again, these means were associated with wide variation in 
scores. However these results confirm that processing speed (as demonstrated 
in coding and Trails A) and executive functioning (as demonstrated by the Brixton 
and Hayling tests) are amongst the most affected in this sample. 
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Figure 3.2-1 Histogram of Group Test Means
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Table 3.2-1 Descriptive Statistics & Analyses of Distribution for Neuropsychological 
Test Data 
 Min 
 
Max 
 
Mean SD Skewness 
 
Kurtosis Shapiro-
Wilk (Sig) 
Digit Forward (scaled) 2 15 7.50 4.243 .284 -1.113 .428 
Digit Backward (scaled) 2 12 6.44 2.920 .385 -.713 .255 
Coding (scaled) 1 14 3.94 3.838 1.518 1.926 .005 
Figure Copy (scaled) 1 14 9.88 4.588 -1.229 -.072 .001 
Line Orientation (scaled) 3 15 10.12 3.243 -.516 -.092 .734 
Picture Naming (scaled) 1 12 9.19 3.816 -1.201 .064 .001 
List Total (scaled) 1 14 5.81 4.053 .663 -.588 .247 
List Delay (scaled) 1 14 7.13 4.129 .470 -.816 .255 
List Recognition (scaled) 1 12 5.50 4.817 .397 -1.852 .003 
Story Immediate (scaled) 1 17 7.50 4.967 .397 -.662 .390 
Story Delay (scaled) 1 15 7.19 4.722 .205 -1.231 .349 
Figure Delay (scaled) 2 16 9.00 4.163 .032 -.905 .824 
Fluency - Letter (scaled) 1 19 8.69 5.351 .216 -.922 .573 
Fluency - Category 
(scaled) 
1 19 7.13 5.726 .659 -.600 .182 
Fluency - Switches 
(scaled) 
1 15 6.88 5.005 .347 -1.407 .051 
Verbal Production 
(Scaled) 
1 14 6.00 3.967 .249 -.619 .257 
Spatial Span (scaled) 4 15 8.19 3.188 .652 -.181 .125 
Brixton (scaled) 1 12 5.56 3.949 .261 -1.226 .063 
Hayling 1 Basic (scaled) 1 6 3.62 2.062 -.047 -1.702 .007 
Hayling 2 Inhib (scaled) 1 6 3.44 2.308 -.057 -2.043 .001 
Trail Making A (scaled) 1 12 5.13 4.455 .360 -1.830 .004 
Trail Making B (scaled) 1 13 7.06 4.008 -.180 -1.351 .434 
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3.3 Relationships between Tests 
Spearman’s rho analyses were conducted in order to explore relationships between 
variables. Scaled scores from all participants were entered into the analysis. 
However one of the participant’s did not wish to undertake the WTAR test. 
Consequently the data was excluded pairwise (i.e. the data obtained for this 
participant was included for all calculations except those in which they had no score; 
Field, 2011). The following sections provide a summary of the key associations 
found, and report on medium to large effect sizes (i.e. 0.30 or greater, as guided by 
Cohen, 1992) 
 
See Appendix G for the full correlation matrix). 
 
3.3.1 Demographic Data 
Data obtained from this sample suggests that in terms of demographic variables 
(age, years of education, WTAR, CD4 counts, and viral load) a strong correlation 
was found between CD4 counts and viral load (r = -.794).  This finding is in keeping 
with what would be expected in the HIV population i.e. as viral loads increase, CD4 
counts decrease. A medium effect was found between WTAR and education (r = 
.433) and again this was in keeping with what would be expected. 
 
3.3.1.1 CD4 Counts, Viral Loads, and Test Performance  
CD4 counts were found to be correlated with story learning (r = .441), verbal 
production (r = .578) and spatial span (r = .627). Viral load was found to be 
negatively correlated with the WTAR (r = -.428) digit span forwards (r = -.544), 
verbal production (r = -.675) spatial span (r = -.595), and letter fluency (r = -.482).  
 
3.3.1.2 Age and Test Performance  
Age was found to be significantly related to figure copy scores (r = .542) and spatial 
span (r = .518).  
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3.3.1.3 Education and Test Performance  
Education was significantly correlated with core cognitive functions (e.g. coding r = 
.557; story immediate recall r = .570; story delayed recall r = .614; list learning r = 
.632; list delay r = .545; figure copy r = .817; figure delay r = .786).  
 
It was also found to be correlated with executive function skills (digit backwards r = 
.704; letter fluency r = .638; category fluency r = .669; switching fluency r = .626; 
Hayling 1 initiation trial r = .562; Trails A r = .666; Trails B r = .514; spatial span r = 
624). 
  
The relationships found between education and test performance are in keeping with 
what would be expected, and previous literature would suggest that education has a 
positive relationship with test performance (e.g. Grant 2008). 
 
3.3.1.4 Premorbid Ability and Test Performance  
Premorbid ability, as established by WTAR scores, was found to be associated with 
core cognitive tests (e.g. list learning r = .614; story delayed recall r = .611) and 
executive function tests (e.g. digit span backwards r = .720; Brixton test r = .448; 
Hayling 1 r = .435; Trails A r = .454). 
 
3.3.2 Attention & Information Processing 
Digit span forward was found to be strongly associated with digit span backward (r = 
.663). Coding was found to be strongly associated with figure copy (r = .633), figure 
delay (r = .745) and spatial span (r = .646) perhaps highlighting some the common 
skills shared by these tests (motor control, attention, visuo-spatial perception). 
Coding was also strongly associated with letter fluency (r = .662), category fluency (r 
= .624), and switching fluency (r = .588) perhaps reflecting the shared speed of 
information processing involved. 
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3.3.3 Visuo-Spatial Skills 
Visuo spatial skills were assessed using line orientation and figure copy subtests. 
Line orientation was found to be correlated with picture naming (r = .502), Trails A (r 
= .568) and Trails B (r = .704). Figure copy was correlated with spatial span (r = 
.660) and Trails A  (r = .709). These correlations point to the shared functions 
necessary for completion of these tests e.g. attention and visuo-spatial perception. 
 
3.3.4 Learning & Memory 
Tests of new learning and delayed recall were all found to be strongly associated 
with each other and this finding is in keeping with what would be expected given that 
they address similar skills. Interestingly associations were also found across 
modalities; figure recall was associated with list recall (r = .792) again highlighting 
the core functions shared by these tasks (e.g. attention, memory formation, and 
recall skills).  
 
They were also found to be associated with other domains. E.g. letter fluency was 
strongly associated with list learning (r = .827), category fluency associated with 
story recall (r = .843). Again these results are likely to reflect commonality in what 
these tests assess  (e.g. language and memory retrieval strategies). 
 
3.3.5 Executive Function  
As noted above, executive functions were strongly associated with memory ability 
and visuo-spatial perception.  
 
It was also found that executive function skills were associated with each other in 
this sample. For example correlations were found between executive verbal skills 
(e.g. Hayling 1 and letter fluency, r = .672; Hayling 2 and category fluency, r = .639) 
and between visuo-spatial executive skills (e.g. Trail Making A and spatial span, r = 
.507). Correlations were also found in tests of different modalities (Hayling 1 and 
Trails A, r = .855; Hayling 2 and Trails B, r = .694).  These findings are perhaps 
suggestive of functions shared by these processes e.g. attention, concentration, rule 
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formation, and retrieval skills. 
 
Figure 3.2-1 highlighted that in terms of group means Hayling 1 and 2 had the lowest 
scores (alongside Trails A and coding) whilst letter fluency, category fluency, 
switching and Trails B were stronger. However Hayling 1 was positively correlated 
with letter fluency (r = .672), category fluency (r = .795) switching (r = .667) and 
Trails B (r = .690). Similarly Hayling 2 was also positively correlated with all of these 
skills (letter fluency, r = .633; category fluency, r = .639; switching, r = .699; Trails B, 
r = .694). These correlations between the strongest and weakest executive function 
tests may indicate that Hayling 1 and 2, whilst assessing abilities common to the 
other tests (hence their positive correlations), may also tap into functions which are 
not assessed by other tests, and which degenerate earlier in this group (i.e. verbal 
initiation and inhibition). 
 
 
3.4 Individual Profile Analyses 
 
Barker et al. (2003) note that individual case analysis allows for a closer inspection 
of factors that may be missed in group level analyses, and also an exploration of 
whether group indices shed any new light on relationships between scores in 
individuals. Since this study took an exploratory approach, this part of the analysis is 
particularly important.  
 
Further, it would be useful to consider the extent to which group differences are 
reflected in individual scores since the group level means were associated with large 
standard deviations. Consequently neuropsychological profiles and prominent 
background factors for each participant were explored.  
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3.4.1 Participant 1 
 
3.4.1.1 Background Information 
Participant 1 is a 23-year old female of Black British (Nigerian) origin. She moved to 
England with her family shortly after birth and attended full time education until the 
age of 21. She has a degree in History and at the time of her admission, was training 
to be a professional chef.   
 
This participant was diagnosed with HIV at the age of 2. She started taking anti-
retroviral medication at the age of 10, though used it intermittently until the age of 
fifteen due to intolerable side effects. She has a long-standing history of chest 
infections. At the age of 21 she was found to have a rectovaginal fistula and had to 
have an ileostomy. She has a history of depression but did not report low mood at 
the time of testing. Her CD4 count is 57 and her viral load 59000. 
 
3.4.1.2 Primary Task Scores 
Primary task scores for Participant 1 are shown in Figure 3.4-1. 
 
Participant 1 had a WTAR score suggesting high average premorbid ability.   
 
This participant had intact verbal attention skills (digit span forward subtest) and 
working memory (digit span backwards subtest).  
 
Her performances on tests of information-processing speed, visuo-spatial 
perception, language, new learning, and recall were all intact. However her verbal 
production score was impaired and therefore not in keeping with what would be 
expected given her profile. It may be the case that this participant failed to grasp the 
basic rubric of the test, and thus adopted a defective strategy.   
 
This participant’s strongest performances were in tests of verbal and semantic 
fluency, indicating sound word generation ability. Performances on a test of rule 
deduction (Brixton), and visual sequencing and switching were also in tact. Her 
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weakest executive skills appeared to be in the area of verbal initiation and inhibition 
(Hayling 1 and 2), perhaps indicating poorer executive control of verbal rules.  
 
3.4.1.3 Summary & Discussion of Participant 1 
This participant acquired HIV at a young age, possible through vertical transmission, 
and there are a number of authors reporting the impact of this on cognition. For 
example Ravindran, Rani and Priya (2014) showed poorer performances on tests of 
attention, language, verbal memory and learning, and executive functioning in a 
sample of 8-15 year olds in comparison to controls. However the experimental group 
for this study was recruited from a care home for children with HIV in India, whilst the 
control group all resided with their parents; performance in part may therefore have 
been attributable to the social circumstances of the participants. Nagarajan et al 
(2012) however report similar findings in their study when comparing performances 
of sixteen children with HIV to those of fourteen controls, all of whom were living with 
their families in Los Angeles.   
 
Paramesparan et al. (2010) explored the cognitive function of vertically infected 
children surviving into adulthood since these individuals will have undergone stages 
of neurodevelopment in the presence of HIV infection and cART. They reported 67% 
of their sample had impairments in psychomotor function, executive function, 
memory and attention, noting this to be much higher than those with horizontal 
transmission rates (19%).  
 
Interestingly, Participant 1 did not appear to demonstrate impairments inline with the 
literature above. The cognitive reserve hypothesis may be helpful in explaining her 
performance, and it may be the case that her educational and occupational 
achievements curbed the impact of any pathology.  
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Figure 3.4-1 Histogram of Scaled Scores for Participant 1 
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3.4.2 Participant 2 
 
3.4.2.1 Background Information 
Participant 2 is a 46-year old male of British (Indian) origin. He was born in India and 
moved to the UK at the age of 4. He was expelled from school at the age of 15 and 
spent some time in prison before moving to Canada to start a business. He was 
diagnosed with HIV at the age of 26. He has a longstanding history of drug and 
alcohol use, and attended rehabilitation for this in the past. He is currently 
maintained on methadone. He was diagnosed with tuberculosis in 2010. His CD4 
count is 32 and his viral load 1196.  
 
3.4.2.2 Primary Task Scores 
Primary task scores for Participant 2 are shown in Figure 3.4-2 Histogram of 
Scaled Scores for Participant 2. 
 
Participant 2 had a WTAR score suggesting average premorbid ability. This 
participant demonstrated relative strengths in language, visuo-spatial perception, 
semantic fluency, and tests of sequencing and switching. However the profile 
showed severe impairment in coding; other areas of weakness included new 
learning and delayed recall of verbal information though registration appeared 
slightly stronger. Visuo-spatial memory was also slightly lower than expected.  
 
Performances in tests of spatial attention were within the below normal range 
perhaps indicating weaker visual working memory; verbal initiation and inhibition 
were also below normal perhaps indicating weaknesses in executive components of 
semantic recall processes and new rule formation.  
 
3.4.2.3 Summary & Discussion of Participant 2 
This participant presented with impairments in processing speed, attention, verbal 
executive skills, new learning, and delayed recall of verbal information.  HIV infection 
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may have played a part in this presentation, however a number of comorbid risk 
factors may also have contributed to the profile.  
Patel et al (2013) note that substance misuse is common in the HIV population and 
there is a greater risk of poor cART adherence, thus leading to poorer clinical 
outcomes. Mintzer, Copersino and Stitzer (2005) found attention, information 
processing speed, and working memory deficits in those engaged in methadone 
maintenance therapy. However Applebaum, Otto, Richardson and Safren (2010) 
compared the performance of 80 opiate-dependent HIV+ participants to 80 opiate 
dependent HIV- participants recruited from methadone clinics, and were unable to 
replicate the findings of Minzter et al,; they reported that when exploring the 
respective roles of depression, HIV and substance misuse with multiple regression 
analyses, only HIV status was found to be predictive of neuropsychological 
impairment, particularly on tests of attention, speed and verbal memory. However, 
the authors noted that neuropsychological performance across both groups was 
poor and this may have impacted the ability of the study to find more divergent 
profiles.  
 
In summary although the literature suggests a strong role for HIV in this 
neuropsychological profile, it is also likely that substance use, and possibly 
methadone, contributed to the findings.    
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Figure 3.4-2 Histogram of Scaled Scores for Participant 2 
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3.4.3 Participant 3 
 
3.4.3.1 Background Information 
Participant 3 is a 40-year old female of Nigerian origin. She reported attended school 
in Nigeria until the age of 12 and then studied quantity surveying for four years. She 
arrived in the UK three months prior to her admission to the HIV unit, and was 
diagnosed with HIV one month prior to her neuropsychological assessment. A recent 
MRI reported evidence indicative of toxoplasmosis. Her CD4 count is 177 and her 
viral load 202.  
 
No further collateral information was available for this participant 
 
3.4.3.2 Primary Task Scores 
Primary task scores for Participant 3 are shown in Figure 3.4-3. 
 
Participant 3 had a WTAR score suggesting low average premorbid ability. Her 
profile highlighted relative strengths in visuo-spatial perception (line orientation), and 
verbal and visuo-spatial attention. However poorer performances were noted in tests 
involving motor functioning (figure copy, coding) perhaps indicating impairment in 
motor skills and psychomotor slowing. Impairments in immediate and delayed visual 
and verbal memory were also observed (list learning, delayed list recall, list 
recognition, story learning, delayed story recall, and figure recall subtests). 
 
On the executive function tests, letter fluency was slightly stronger than category 
fluency though performances on both tests fell within the impaired range perhaps 
indicating weaknesses in word generation and strategy formation techniques. 
However these results may be the consequence of a more general language 
impairment, since her performances in all tests involving language functioning fell 
within the impaired range; an alternative explanation to account for the results is that 
the performances were impacted by English being her second language. Poor 
performance in the Brixton test may indicate poor rule deduction.  
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3.4.3.3 Summary & Discussion of Participant 3 
This participant presented with impaired performances in many domains including 
motor functioning, memory, language, and executive functioning.  
 
As noted above, English being her second language may have impacted some of 
this participant’s performances. However since she also scored lower than expected 
on tests involving visual components (e.g. copying, rule deduction) it may be the 
case that other factors, for example HIV-associated impairment, also played a role in 
the profile. Further, Levine et al (2008) conducted an exploratory study suggesting 
that in comparison to HIV+ participants without evidence of central nervous system 
opportunistic infections (such as toxoplasmosis) those with these conditions had 
poorer neuropsychological functioning in general, but performed significantly poorer 
on measures of processing speed. However the authors argue that since processing 
speed is a key deficit reported in those with HAND, it may be the case that these 
opportunistic infections potentiate the effects of HIV on cognition.  
 
The above study may provide an explanation for this participant’s poor performances 
on tests with timed components e.g. coding, Hayling tests, fluency. Further this may 
also explain the finding that she performed significantly better on Trails B than Trails 
A; success in Trails A is significantly dependent on processing speed, whilst Trails B 
is also dependent on executive switching. This finding would therefore suggest that 
executive switching is less impaired for this participant.    
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Figure 3.4-3 Histogram of Scaled Scores for Participant 3 
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3.4.4 Participant 4 
 
3.4.4.1 Background Information 
Participant 4 is a 43-year old male of Congolese origin, who received 9 years of 
formal education. He moved to England at the age of 26 and worked as a taxi driver 
and security guard.  He was diagnosed with HIV in 1996 and had a brain tumour 
removed in 1998. He has a history of tuberculosis. He was admitted to the unit for 
rehabilitation following a fall. His CD4 count is 479 and his viral load was <40 
(undetectable).  
 
3.4.4.2 Primary Task Scores 
Primary task scores for Participant 4 are shown in Figure 3.4-4. 
 
Participant 4 had a WTAR score suggesting average premorbid ability. His scores 
on tests of attention were lower than expected. Motor difficulties were evident in the 
coding, figure copy, and Trials A subtests, although higher performances on the line 
orientation and picture naming tests suggest visuo-spatial perception is intact.  
 
On verbal memory tests, performances suggested impaired registration and 
learning, and below normal memory for unconnected verbal information. In 
comparison, immediate and delayed recall on subtests involving semantically 
connected information (story-learning) was stronger. 
 
On tests of executive functioning, phonetic and semantic fluency were within the 
average range suggesting intact word generation and strategy formation skills. 
Further, switching was one of the strongest skills in this profile (verbal switching and 
Trails B) indicating intact cognitive flexibility. However response initiation and 
inhibition (Hayling test 1 and 2) were within the below normal and impaired ranges 
respectively. 
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Visuo-spatial attention appeared intact (spatial span) and there was also evidence of 
sound rule deduction skills (Brixton).  
 
3.4.4.3 Summary & Discussion of Participant 4 
This participant performed lower than would be expected in motor skills, processing 
speed, attention, new learning, verbal initiation and inhibition. However he also 
demonstrated strengths in other areas including visuo-spatial perception, delayed 
recall, verbal fluency and switching. Interestingly, this participant performed more 
poorly on Trails A (a test of processing speed) in comparison to Trails B (a timed test 
of visual switching). It may be argued that, since performance on the coding task 
was also impaired, it is likely that this participant’s performance suggests that 
processing speed is more impaired than executive skills in this case. However as 
noted above, performances in other executive skill tests fell in the impaired ranges. 
 
In summary, it may be argued that although there was some evidence of HIV 
associated decline, this participant’s performance led to a ‘patchy’ profile. This may 
be the result of a number of protective factors including a (relatively) high number of 
years of formal education and a low viral load.    
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Figure 3.4-4 Histogram of Scaled scores for Participant 4 
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3.4.5 Participant 5 
 
3.4.5.1 Background Information 
Participant 5 is a 57-year old male of British origin. He reported leaving school at the 
age of 16 and having a number of occupations throughout his life including making 
silverware and being a cleaning supervisor at a shopping centre. He was diagnosed 
with HIV two months before his neuropsychological assessment. He has 
pancytopenia, pneumocystis pneumonia, and Kaposi’s Sarcoma of the face, palette 
and tongue. He was receiving treatments for these conditions. His CD4 count is 38 
and his viral load 3 million.  
 
3.4.5.2 Primary Task Scores 
Primary task scores for Participant 5 are shown in Figure 3.4-5. 
 
Participant 5 had a WTAR score suggesting below normal premorbid ability.  
In line with this attention and information processing speed were also found to be 
within the below normal range. However motor skills, visuo-spatial perception and 
naming to confrontation appeared to be intact (figure copy, line orientation, and 
picture naming subtests), in addition to recall of visuo-spatial information (figure 
delayed test). Registration, learning and memory for verbal information were within 
the low average range (list learning, list recall, list recognition, story learning, and 
story recall subtests).  
 
Verbal fluency appeared to be intact, though semantic fluency and verbal switching 
were particularly strong indicating sound executive language ability and cognitive 
flexibility. Visual sequencing and switching (Trails A and B) also appeared intact. 
However verbal initiation and inhibition were below normal. 
 
3.4.5.3 Summary & Discussion of Participant 5 
This participant had a low WTAR score, and performances in attention, processing 
speed, verbal initiation and inhibition were in line with this. However, this participant 
performed higher than would be expected given his estimated premorbid ability level 
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in other domains; motor functioning, language, visuo-spatial perception, memory, 
fluency and switching all fell within average ranges.  
 
It is difficult to explain this anomaly. One explanation may be that, since this 
participant attended formal education until he was 16, he was able to grasp the 
rubric of the assessment effectively thus supporting his performances. It may also be 
the case that this participant may have poorer reading skills given his occupational 
status, and therefore the WTAR may have provided a conservative estimate of his 
overall abilities.  
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Figure 3.4-5 Histogram of Scaled scores for Participant 5 
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3.4.6 Participant 6 
 
3.4.6.1 Background Information 
Participant 6 is a 56-year old male of Ghanian origin. He reported attending formal 
schooling in Ghana between the ages of 7-16. He then trained to be a teacher, and 
taught primary school children for 15 years.  He immigrated to England at the age of 
44. He had a stroke in the same year, and was diagnosed with HIV in 2006. He also 
has a history of toxoplasmosis. His CD4 count is 680 and his viral load <40 
(undetectable).  
 
3.4.6.2 Primary Task Scores 
Primary task scores for Participant 6 are shown in Figure 3.4-6. 
 
Participant 6 had a WTAR score suggesting average premorbid ability. Verbal and 
visuo-spatial attention test performances were in line with this (digit span and spatial 
span subtests).  
 
Performances on tests involving motor function, attention and psychomotor speed 
were impaired across the profile (coding, Trials A & B). However this participant’s 
score on the figure copy subtest, which only has a motor component and is not 
performed under time pressures like the previous three subtests, was intact. 
 
Visuo-spatial perception also appeared intact (line orientation), alongside visuo-
spatial memory (figure delayed recall subtest).  
 
In terms of verbal memory, list learning was impaired though recall was stronger 
suggesting that although the capacity for learning information may be impaired, what 
is learned is retained. However on the story learning subtest, learning trial scores fell 
within the average range, suggesting that it was easier for this participant to learn 
semantically connected information.  
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Performance was intact in the letter fluency subtest, however impaired in the 
category fluency subtest suggesting some difficulties with semantic retrieval, rather 
than a language impairment per se. Impaired performance on the verbal switching, 
initiation, and inhibition subtests provided evidence of difficulties in cognitive 
flexibility.  
 
3.4.6.3 Summary & Discussion of Participant 6 
This participant presented with impairments in motor functioning, attention, 
psychomotor speed, category fluency, verbal switching, verbal initiation and 
inhibition.  
 
It may be that some of the impairments are attributable to HIV, however this 
participant presented with a number of comorbid factors which may also have 
negatively impacted his performances. This participant had toxoplasmosis, and as 
noted above in the case of participant 3, Levine et al (2008) argue that such 
opportunistic infections appear to exacerbate cognitive impairments in those with 
HIV.  
 
Further, this participant had a stroke at the age of 44. Patel et al (2013) note that 
those with HIV demonstrate a higher prevalence of vascular risk factors than the 
general population, and Foley et al (2010) reported poorer cognitive profiles, with 
cardiovascular factors and HIV negatively impacting processing speed, 
learning/memory, and executive functioning. Consequently, it may be the case that 
this participant’s vascular history contributed to his performance.  
  
Also worthy of note, this participant was born and schooled in Ghana and a number 
of authors have agued that neuropsychological assessments designed in the West 
are unsuitable for people from different cultures (e.g. Shah, Oomen, & Wuntakal, 
2005).   
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Figure 3.4-6 Histogram of Scaled scores for Participant 6 
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3.4.7 Participant 7 
 
3.4.7.1 Background History 
Participant 7 is a 49-year old male of Congolese origin, who was diagnosed with HIV 
in 1997. He had tuberculosis in 2008. His CD4 count is 75 and his viral load 916.  
 
In the clinical interview this participant reported arriving in the UK one month before 
his admission to the HIV unit. He declined the opportunity to provide any further 
collateral information.  
 
3.4.7.2 Primary Task Scores 
Primary task scores for Participant 7 are shown in Figure 3.4-7. 
 
Participant 7 had a WTAR score suggesting impaired premorbid ability. 
Performances in line with this were evident throughout the assessment, with 
impairments detected in attention and information processing, language, and verbal 
functions (learning, recall, initiation, inhibition, and cognitive flexibility).  
 
However this participant had relatively strong performances in subtests involving 
visuo-spatial skills (including figure copy, line orientation, delayed figure recall and 
spatial span), indicating an area of preserved ability.  
 
3.4.7.3 Summary & Discussion of Participant 7 
This participant’s profile indicated impairment in many domains, however visuo-
spatial skills were in tact. It is likely that HIV and toxoplasmosis played a role in the 
results, alongside issues relating to the suitability of the assessment battery for a 
person from a different cultural background, however it is difficult to fully 
contextualise this participant’s profile given the limited collateral information.  
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Figure 3.4-7 Histogram of Scaled scores for Participant 7 
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3.4.8 Participant 8   
 
3.4.8.1 Background History  
Participant 8 is a 48-year old male of Ugandan origin. He reported attending formal 
education until the age of 16 and then working in the family business. He arrived in 
the UK at the age of 46.  
 
Participant 8 was diagnosed with HIV in 1992, aged 27. He has a history of 
depression and PTSD but was reportedly stable at the time of neuropsychological 
assessment. He also has a history of tonic-clonic seizures, and an MRI indicated 
‘non-specific deep white matter signal abnormality in the left parietal lobe’. His CD4 
count is 241 and his viral load 1386132.  
 
3.4.8.2 Primary Task Scores 
Primary task scores for Participant 8 are shown in Figure 3.4-8. 
 
Participant 8 had a WTAR score suggesting average premorbid ability. Performance 
in an assessment of verbal attention (digit span) was in line with this, as were 
performances in assessments of visuo-spatial skills (figure copy and line 
orientation).  
 
However impairments in other domains were observed throughout the assessment. 
Language impairments were observed in tests of naming to confrontation, letter 
fluency, semantic fluency, verbal switching, verbal initiation and inhibition. Verbal 
memory functioning (registration, learning, delayed recall) was also impaired 
alongside visuo-spatial memory. Further, performances in tests of executive 
functioning highlighted impairments in rule deduction, sequencing and switching 
(Brixton, Trails A, Trails B, and category switching).    
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3.4.8.3 Summary & Discussion of Participant 8 
This participant’s profile indicated strengths in attention and visuo-spatial skills, 
though impairments in other domains were evident.  
 
Although this participant reported receiving 12 years of formal education, and 
therefore would be expected to have reasonable cognitive reserve, he also 
presented with a number comorbid conditions, all of which may be impacting his 
profile. For example depression has been associated with poorer performances on 
effortful tasks such as those with timed components (e.g. Coding, Trails). However 
since the participant did not report any current difficulties with depression, and 
Gibbie et al (2006) argue that an improvement in neurocognitive test scores can 
occur in those with HIV who have been treated for their low mood, other factors may 
have been at play in this particular profile. 
 
Moradi et al. (2013) reported that those in their study with comorbid PTSD and HIV 
performed worse on executive tests (the Wisconsin Card Sorting Test and the Tower 
of London Test) than controls. Further parietal lobe functioning has been implicated 
in language production (Lezak et al., 2004) and this participant’s MRI indicated some 
evidence of abnormality in this area.  
 
Further Lee and Clason (2008) highlight the impact of epilepsy on learning and 
memory.  
 
In summary, this participant presented with a number of comorbid risk factors in 
addition to HAND which may have impacted his cognitive and executive profiles.  
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Figure 3.4-8 Histogram of Scaled scores for Participant 8 
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3.4.9 Participant 9 
 
3.4.9.1 Background History 
Participant 9 is a 54-year old female of Zimbabwean origin, who reported attending 
fulltime education from the age of 7 for four years. She worked as an insurance clerk 
until she moved to England at the age of 39. She then became a professional carer.  
 
Participant 9 was diagnosed with HIV three months prior to admission. Her CD4 
count is 2 and her viral load 100 million.  
 
3.4.9.2 Primary Task Scores 
Primary task scores for Participant 9 are shown in Figure 3.4-9. 
 
Participant 9 had a WTAR score suggesting below normal premorbid ability. 
Performances in verbal and visuo-spatial assessments of attention (digit span and 
spatial span subtests) were in line with this. Performance on a test of attention 
involving motor skills and information processing speed was within the impaired 
range. 
 
This participant gave her strongest performances in tests of visuo-spatial perception 
(figure copy, line orientation, and picture naming subtests). However on an 
assessment of visuo-spatial memory (figure delayed recall) she scored within the 
below normal range.  
 
In terms of verbal abilities this participant appeared to demonstrate impairment in 
new learning (list learning and story learning subtests), recall (list delay and story 
delay subtests), and registration of verbal information (list recognition subtest).  
 
On assessments of executive function, this participant scored within the impaired 
range on tests of rule deduction (Brixton), verbal initiation and inhibition (Hayling 1 
and 2), word generation/fluency, and verbal switching. She scored within the below 
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normal range on a nonverbal assessment of switching and sequencing (Trails B). 
This is an anomaly given her weaker performance in Trails A and is likely to reflect 
further evidence of impaired processing ability, though with some degree of 
preserved cognitive flexibility.  
 
3.4.9.3 Discussion & Summary of Participant 9 
This participant’s relative strengths were in visuo-spatial skills. However her 
performances were impaired in all other domains. Although some of these 
performances were in line with what would be expected given estimates of her 
premorbid functioning level, it may also be the case that this estimate is of limited 
clinical utility since she received only 4 years of formal education. It is therefore likely 
that disease severity (as indicated by her low CD4 count and high viral load) 
impacted her performances in this assessment (Heaton et al., 2011) alongside 
factors such as limited cognitive reserve.   
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Figure 3.4-9 Histogram of Scaled scores for Participant 9 
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3.4.10 Participant 10 
 
3.4.10.1 Background Information 
Participant 10 is a 47-year old female of Ugandan origin who immigrated to the UK 
at the age of 26. She declined the opportunity to provide any further collateral 
information, noting only that she worked as a teacher. 
 
Participant 10 was diagnosed with HIV two months prior to admission. Her CD4 
count is 77 and her viral load 80,000. There was no evidence of opportunistic 
infections or other illnesses in the medical notes.  
 
3.4.10.2 Primary Task Scores 
Primary task scores for Participant 10 are shown in Figure 3.4-10. 
 
Participant 10 had a WTAR score suggesting average cognitive ability. Her 
performances on tests of attention and information processing fell within the 
impaired range.  
 
Performances on assessments of visuo-spatial perception (line orientation and 
picture naming subtests) were within the high average range. Her performance on 
the figure copy task fell within the below normal range, and this may have been the 
result of impaired motor functioning, as demonstrated by her poor performances on 
other tests with psychomotor components (coding, Trails A, Trails B). 
 
Assessments of immediate memory and delayed recall fell within the below normal 
range, though memory for a story was stronger than memory for a list of words.  
 
This participant scored within the impaired range on tests of verbal fluency/word 
generation (letter fluency and category fluency subtests), rule deduction (Brixton), 
verbal initiation and inhibition, and visual sequencing and switching. Her 
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performance on a test of spatial attention was her strongest in the executive function 
tests. 
 
3.4.10.3 Summary & Discussion of Participant 10 
This participant’s profile demonstrated relative strengths in visuo-spatial perception 
and spatial attention. Although there was also some evidence of delayed memory 
ability, clear impairments were observed in all other cognitive domains and executive 
function skills. Interestingly, this participant performed relatively better on digit span 
backwards in comparison to digit span forwards. It may be the case that this is the 
result of impaired attentional skills, whilst also suggesting that working memory is 
relatively stronger in comparison to other skills. 
 
In the absence of other collateral information, it is likely that this participants profile is 
reflective of disease severity, and therefore of HAND.   
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Figure 3.4-10 Histogram of Scaled scores for Participant 10 
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3.4.11 Participant 11 
 
3.4.11.1 Background Information  
Participant 11 is a 67-year old male of British origin. He was educated to degree 
level in Scotland before pursuing a career in the air force, and then later a career in 
the construction industry abroad.  
 
Participant 11 returned to England one month before his admission to the HIV unit 
and received his diagnosis following a fall.  
 
His CD4 count is 180 and his viral load 140. There was no evidence of opportunistic 
infections or other illnesses in the medical notes.  
 
3.4.11.2 Primary Task Scores 
Primary task scores for Participant 11 are shown in Figure 3.4-11. 
 
Participant 11 had a WTAR score suggesting superior premorbid ability. His verbal 
attention skills appeared to be inline with this, however on an assessment of 
processing speed he scored within the impaired range. This finding may have been 
accounted for by the participant reporting a sprained wrist, however on other ‘pen 
and paper’ tests with time pressures (Trails A and B) his performances were within 
the average ranges.  
 
Visuo-spatial perception and visuo-spatial memory appeared to be intact. New 
learning of verbal information and delayed verbal recall was also intact, with story 
learning and delayed story recall being particularly strong (superior range). 
 
Performances on the executive function battery were more variable; verbal fluency 
(both letter and category), verbal and visual switching, and visual sequencing were 
intact. Performance on a test of spatial attention (spatial span) was particularly 
Page 92 of 183 
strong. However performances on tests of rule deduction (Brixton), and verbal 
initiation and inhibition fell within the impaired ranges.   
 
3.4.11.3 Summary & Discussion of Participant 11 
Participant 11 presented with a number of strengths across his profile. It is difficult to 
know exactly when he acquired HIV, however it may be inferred from his profile that 
any resultant cognitive impairments are yet to emerge. It may also be the case that 
he has relatively strong cognitive reserve as indicated by his educational and 
occupational history, and this may have played a role in the strong performances he 
gave. 
 
However this participant’s score on coding and verbal production (assessments of 
processing speed) were not in keeping with the rest of his cognitive profile. Further, 
in terms of his executive skill profile, his performances on the Brixton and Hayling 
tests were lower than expected. Since Participant 11 tended to perform relatively 
lower on tasks involving speed or those with timed-components, this may have 
accounted for his performances in the Hayling tests, were processing speed is a key 
component.   
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Figure 3.4-11 Histogram of Scaled Scores for participant 11 
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3.4.12 Participant 12 
 
3.4.12.1 Background Information  
Participant 12 is a 26-year old female of Kenyan origin. She moved to England at the 
age of 16 and recently enrolled in a nursing course.  
 
Participant 12 was diagnosed with HIV and pneumocystis pneumonia in 2004. In 
2010 she was diagnosed with toxoplasmosis and tuberculosis. She has a diagnosis 
of delirium with psychotic features although was stable at the time of 
neuropsychological assessment. Her CD4 count is 4 and her viral load 1.1 million 
 
3.4.12.2 Primary Task Scores 
Primary task scores for Participant 12 are shown in Figure 3.4-12. 
 
Participant 12 had a WTAR score suggesting very impaired premorbid ability. Her 
scores on tests of attention, working memory, and information processing were in 
line with this.  
 
Her performances on tests of visuo-spatial perception and visuo-spatial memory fell 
within the average ranges, thus indicating an area of preserved ability. 
 
This participant was impaired in tests assessing list learning; however her scores on 
the registration task (list recognition) fell within the high average range suggesting 
that whilst registration of new information is intact, processes involved in learning 
and memorising were impaired. Her performances on story learning and recall fell 
within the average range, suggesting that this participant was able to utilise 
previously learned semantic rules to support learning and memory (a strategy she 
may not have been able to utilise when learning a list of unconnected words).  
 
In terms of executive functioning, letter fluency was intact suggesting preserved 
verbal executive skills. However category fluency fell in the below normal range 
perhaps suggesting an impairment in semantic memory, or in contrast to her 
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stronger performance on story recall where information was coherently presented to 
her, an impairment in retrieval strategies. However her verbal switching ability was 
intact.  
 
Finally, performances in spatial attention, rule deduction, verbal initiation, verbal 
inhibition, visual sequencing and visual switching all fell within the below normal and 
impaired ranges suggesting poor executive flexibility and functioning.  
 
3.4.12.3 Summary & Discussion of Participant 12 
Participant 12 presented with strengths in visuo-spatial skills, registration, and story 
learning. However impairments were observed in attention and list learning. In terms 
of the executive function profile, this participant presented with strengths in letter 
fluency and switching but poorer performances on other measures.  
 
There are a number of factors that may have impacted this participant’s 
performances. Low CD4 counts and high viral load may have impacted the result 
(Heaton et al., 2011), and her performances on tests of processing speed may have 
been attributable in part to the impact of toxoplasmosis (Levine et al., 2008). Further, 
executive functioning is thought to be impacted by psychotic presentations (e.g. 
Barnett & Fletcher, 2008)   
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Figure 3.4-12 Histogram of Scaled scores for participant 12 
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3.4.13 Participant 13 
 
3.4.13.1 Background Information 
Participant 13 is a 53-year old female of St Lucian origin. She reported attending 
school infrequently until she moved to England at the age of 16, and thereafter 
worked as a machinist for four years.  
 
She was diagnosed with HIV at the age of 32. She has a history of anxiety and 
depression secondary to bereavement, though was stable at the time of her 
neuropsychological assessment. Her CD4 count is 40 and her viral load 100,000 
 
3.4.13.2 Primary Task Scores 
Primary task scores for Participant 13 are shown in Figure 3.4-13. 
 
This participant declined an assessment of premorbid functioning (WTAR).  
She scored within the impaired range for attention, working memory, and information 
processing speed.  
 
Visuo-spatial perception was also within the impaired range alongside visuo-spatial 
memory. Further, immediate memory and delayed recall of verbal information again 
fell within the impaired range, though delayed list recall was slightly stronger.  
 
In terms of executive functioning, this participant’s performance again fell within the 
impaired range; exceptions to this are her scores on switching accuracy (switching 
output) and Brixton (rule deduction), both of which fell within the low average range. 
 
3.4.13.3 Summary & Discussion of Participant 13 
Since participant 13 declined the opportunity to provide an estimate of her premorbid 
ability, comparisons to current functioning were not possible. Another issue that 
impacted formulation is that this participant reported attending school infrequently 
and therefore comparisons of her performance to normative data may not be 
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clinically useful. It may also be the case that her educational status limited her 
cognitive reserve. Further, she presented with high viral load and the impact of this 
on cognitive processes cannot be ignored.  
 
In support of these arguments, impairments were observed in many domains across 
this assessment.  
 
Interestingly, this participant had an area of preserved ability in the language test 
(picture naming). Further her performance on the Brixton test – a test of rule 
deduction which was found to be one of the most challenging for many participants 
in this study – was also one of her strongest. It is difficult to explain this anomaly 
since other performances of executive functioning fell in lower ranges.  
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Figure 3.4-13 Histogram of Scaled scores for participant 13 
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3.4.14 Participant 14 
 
3.4.14.1 Background Information 
Participant 14 is a 50-year old Black British male. He reported attending school until 
the age of 14.  
 
He was diagnosed with HIV at the age of 42 and has a history of frequent 
hyperglycaemic attacks. His CD4 count is 991 and his viral load <40 (undetectable). 
 
3.4.14.2 Primary Task Scores 
Primary task scores for Participant 14 are shown in Figure 3.4-14. 
 
Participant 14 had a WTAR score suggesting average premorbid ability. This was 
inline with his performance on verbal and visuo-spatial tests of attention (digit and 
spatial span subtests). However on an assessment of information processing speed 
he scored within the impaired range indicating psychomotor slowing.  
 
Performances in tests of visuo-spatial perception and visuo-spatial memory were 
within the high average and superior ranges indicating an area of cognitive strength.  
 
List learning and delayed list recall scores fell within the below normal range 
however story learning and story recall scores fell in the average and high average 
ranges, perhaps highlighting stronger skills for learning semantic information. 
 
In terms of performances on assessments of executive function, this participant 
scored within the superior range on letter fluency indicating strong language skills. 
However he scored within the below normal range in the semantic fluency subtest, 
perhaps indicating poor strategies for the retrieval of semantic information.   
 
Performance on a test of rule deduction (Brixton) was within the impaired range. 
Verbal initiation and inhibition scores (Hayling A and B) were within the below 
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normal range, perhaps providing evidence of poor executive control strategies. Trails 
A fell within the average range however Trials B fell in the high average range 
indicating good sequencing and visuo-spatial switching skills.  
 
3.4.14.3 Summary & Discussion of Participant 14 
Participant 14 presented with impaired performances in coding and recognition 
memory, though list learning and list recall were also lower than expected. In terms 
of his executive function profile, Participant 14 presented with weaker performances 
in the Brixton and Hayling tests. McCrimmon, Ryan and Frier (2012) argue that 
cognitive profiles impacted by diabetes show evidence of impaired psychomotor 
slowing and executive functioning. However in this participant’s case it may be that 
processing speed was more impaired than cognitive flexibility, since his score in 
Trails B was higher than scores obtained in the Trails A and coding tests. 
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Figure 3.4-14 Histogram of Scaled scores for participant 14 
 
 
  
0	  2	  
4	  6	  
8	  10	  
12	  14	  
16	  
WTAR	  
	  
Digit	  Sp
an	  (F)	  
Digit	  Sp
an	  (B)	   Coding
	  
Figure	  
Copy	  	  
Line	  Or
ientatio
n	  
Picture
	  Namin
g	  
List	  To
tal	  
List	  De
lay	  
List	  Re
cogntio
n	  
Story	  I
mmedi
ate	  Rec
all	  
Story	  D
elayed
	  Recall
	  
Figure	  
Dealye
d	  Reca
ll	  
Verbal
	  Produ
ction	  	  
Letter	  
Fleunc
y	  
Catego
ry	  Fleu
ncy	  
Switch
	  Fluenc
y	  
Fluenc
y	  Outp
ut	  
Spatial
	  Span	  	   Brixton
	  
Hayling
	  1	  
Hayling
	  2	   Trails	  A
	  
Trails	  B
	  
Sc
al
ed
	  S
co
re
	  
Test	  
Page 103 of 183 
3.4.15 Participant 15 
 
3.4.15.1 Background Information 
Participant 15 is a 72-year old British male, who reports attending full-time education 
until the age of 17. 
 
Participant 15 diagnosed with HIV at the age of 54. He has a history of frequent UTIs 
and is also diabetic. His CD4 count is 359 and his viral load 728. 
 
3.4.15.2 Primary Task Scores 
Primary task scores for Participant 15 are shown in Figure 3.4-15. 
 
Participant 15 had a WTAR score suggesting superior premorbid ability. 
 
This participant’s attention and information processing scores were lower than 
expected given his premorbid ability.  
 
On a line orientation test this participant performed within the below normal range 
however he scored within the superior range on a figure copy test, perhaps 
highlighting a weakness in fine perception ability.  
 
Immediate memory and recall were intact and an area of strength for this participant.  
 
In terms of executive function skills, letter fluency, semantic fluency, and verbal 
switching were all intact, indicating strong word generation and strategy formation 
skills. In comparison to verbal attention (digit span subtest), spatial span was also 
intact. However performances on assessments of verbal initiation, verbal inhibition, 
and spatial rule deduction were lower than expected; this may indicate impairments 
in executive retrieval and perseverance.  
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3.4.15.3 Summary & Discussion of Participant 15 
Participant 15 presented with lower then expected performances in attention, 
working memory, processing speed, and visuo-spatial perception. His performance 
on Digit Span A (a test of attention) was weaker than his performance on Digit Span 
B (a test of working memory). This performance may perhaps suggest that 
attentional processes are more severely impaired and may be the combined result of 
his comorbid conditions, as discussed below.  
 
His executive function profile presented with impaired performances in the Hayling, 
Brixton and Trails tests.  
 
This participant presented with a number of factors that may have impacted his 
cognitive and executive profile including mild/moderate disease severity (Heaton et 
al., 2011), and diabetes (McCrimmon et al., 2012). However, this participant was 
also the eldest participant assessed for this study, and Patel et al (2013) have 
argued that older participants with HIV are more vulnerable to cognitive impairment. 
However, this participant’s profile only demonstrated selected impairments; it may 
be that his premorbid ability i.e. his cognitive reserve, is curbing the impact of 
disease processes.    
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Figure 3.4-15 Histogram of Scaled scores for participant 15 
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3.4.16 Participant 16 
 
3.4.16.1 Background Information 
Participant 16 is a 57-year old American male, who reported attended fulltime 
education until the age of 22. He then developed a career in IT.  
 
Participant 16 was diagnosed with HIV at the age of 33. He suffers from chronic 
inflammatory demyelinising poly-neuropathy. His CD4 count is 300 and his viral load 
<40 (undetectable). There was no evidence of opportunistic infections or other 
illnesses in the medical notes.  
 
3.4.16.2 Primary Task Scores 
Primary task scores for Participant 16 are shown in Figure 3.4-16. 
 
Participant 16 had a WTAR score suggesting superior premorbid ability. His 
performances throughout the assessment were principally in line with this and he 
demonstrated strengths in visuo-spatial perception, visuo-spatial memory, language, 
immediate memory, delayed recall, and attention (although verbal attention was 
much stronger than spatial attention).  
 
Performances on executive function tests were also similarly strong and included 
strengths in verbal fluency, rule deduction and visual switching. However he scored 
lower than expected in tests of verbal initiation and verbal inhibition (Hayling 1 and 
2), perhaps indicating a weakness in verbal initiation and perseveration.  
 
3.4.16.3 Summary & Discussion of Participant 16 
Participant 16 presented with superior premorbid ability. His performances in the 
assessment, though not always in this range, still principally scored at acceptable 
levels, providing little evidence of impairment. However it could be argued that his 
performances fell slightly lower than would be expected given his premorbid ability 
(rather than in comparison to population norms). Further, his performances on the 
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Hayling tests were not in keeping with his profile, indicating some evidence of 
executive difficulty. His performance in Trails B was stronger than his performances 
in Trails A, and as mentioned in discussions of other profiles with similar patterns, 
this may be the result of emerging evidence of processing speed difficulties. 
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Figure 3.4-16 Histogram of Scaled scores for participant 16 
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3.4.17 Summary of Individual Case Analyses 
 
Exploration of individual case profiles highlighted the heterogeneity of the sample in 
terms of age, gender, ethnicity, culture, education, and premorbid ability. All of these 
factors can contribute to the outcome of neuropsychological assessments.  
 
In addition to demographics and HAND, the impact of risk factors on cognition were 
highlighted and discussed within the context of individual profiles. The discussion 
indicates that in the presence of comorbidities, it is difficult to locate impairment only 
attributable to HAND, since the evidence base strongly suggests that these risk 
factors impact domains also affected by HIV. 
 
However group level analyses allow for exploration of commonalities, and these 
include the finding that the Hayling tests were the most difficult to complete for the 
majority of participants. Further, those with English as a second language, or who 
did not receive their education in the West appeared to perform consistently poorer 
than those who were schooled in American and England.  
 
Some of the findings were not in keeping with what would have been expected. For 
example Participant 1 did not display cognitive impairments in line with what would 
be expected of a person who acquired HIV through vertical transmission, and who 
therefore underwent neurodevelopmental stages in the presence of HIV and ART. 
The possible role of cognitive reserve in curbing the effects of the virus was 
highlighted in this case, and in the case of others where disease state and risk 
factors appeared to impacting cognitive processes to a lesser degree than would be 
expected.  
 
Other anomalies observed at the individual case level included stronger 
performances on digit span forwards in comparison to digit span backward, and 
stronger performances on Trails B in comparison to Trails A. These results are likely 
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to reflect impairments in attention and processing speed, and have been discussed 
within the context of individual case profiles where relevant.  
 
It is also worthy of note that four participants declined the request to provide 
collateral information and the reasons for this occurrence within this context may be 
multifactorial; Reid and Walker (2003) highlight that secrecy, mistrust and shame are 
central features of the lived experience of HIV. Further, and in particular to the 
participants of this study, some reported believing that providing this information to 
health professionals may impact their receipt of social benefits and/or result in their 
being deported back to countries they no longer wished to live in.  
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4. DISCUSSION 
 
 
4.1 Summary of Results 
 
This study aimed to explore the cognitive functioning of people with HIV associated 
neurocognitive decline, with a particular focus on exploring whether a ‘profile’ of 
executive function deficits could be identified in this group. 
 
4.1.1 Participant Characteristics  
Reviews of individual profiles (neuropsychological test scores and background 
information) suggested that fourteen participants in the study had mild 
neurocognitive disorder (MND) and two had asymptomatic neurocognitive 
impairment (ANI), as assessed according to diagnostic criteria set by Antinori et al. 
(2007). These presentations were confirmed by multidisciplinary team consensus of 
the service providing assessment and treatment. This is a useful property of the 
sample since Blanch et al. (2012) report that with sensitive measures, HAND is 
detectable even at the earliest stages of disease, thus providing some evidence to 
suggest that the measures used in this study were sufficiently sensitive. 
 
As noted in the results section, CD4 counts were positively correlated, and viral load 
negatively correlated, with verbal production and spatial span. Viral load was found 
to be negatively correlated with digit span forward. These results provide 
confirmatory evidence that psychomotor speed and attention are impacted by 
disease status.  
 
Viral load was also found to be negatively correlated with the WTAR, digit span 
forwards, verbal production, spatial span, and letter fluency (r = -.482). 
However no other correlations were found between these participant characteristics 
and test scores. It may be the case that other correlations were not found due to the 
size of the sample, however Tozzi et al. (2007) reported similar findings; their study 
concluded that test performance was most strongly predicted by severity of cognitive 
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impairment at the point of cART initiation. It was not possible to collect data on cART 
initiation in this sample, and it may be the case that this variable influenced the 
results of the study. Researchers may wish to consider this factor when formulating 
their investigations in the future.    
 
The group level WTAR score indicated that the sample was of typical premorbid 
ability, as found in the general population. This is a useful finding since it allows for 
(cautious) inferences to be made about how HIV may impact different cognitive 
functions.  
 
Both years of education and premorbid ability levels were found to be associated 
with stronger test performances. This finding is in keeping with the current literature 
base (e.g. Farinpour, et al., 2003; Hayman-Abello, 2007; Manly et al., 2011). 
However a strength of the current study is that both years of education and reading 
ability were taken into account in multivariate analyses. It may be the case that these 
two variables are linked to exposure to situations that support stronger test 
performances e.g. familiarity with words, puzzles, language, manipulation of 
information, etc. Other factors that may have played a part in the results (and are 
perhaps linked more to education than premorbid ability) include ‘test-wiseness’, and 
engagement with the testing processes. 
 
More generally, it may also be the case that the cognitive reserve hypothesis can be 
drawn upon here.  The findings of this study were broadly in keeping with this 
hypothesis, and the conclusions of Pereda et al (2000), in that those with higher 
WTAR scores and levels of education tended to show lower levels of decline. A 
further finding of the current study is that those who were schooled in different 
countries generally performed poorer than those who were schooled in the West. 
However they also tended to have fewer years in formal education and this may 
provide some explanation for their lower scores, although cultural factors may also 
have played a part.   
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4.1.2 General Cognitive Function 
Heaton et al. (2011) and Schouten et al. (2011) outlined differences in subcortical 
and cortical impairments associated with HAND, with the former being linked to 
impairments in processing speed and motor skills, and the latter to impairments in 
executive functioning and new learning. The discussion below will highlight that both 
cortical and subcortical features were evident in this sample, and may be linked to 
the documented widening of the cognitive profile associated with HIV infection (e.g. 
Cysique, Maruff & Brew, 2004). 
 
Please see appendix F for subjective range descriptions (based on Slick, 2006). As 
mentioned in section 2.4, standardized scaled scores were used for all statistical 
analyses, thus allowing for comparisons to be made across the different 
batteries/measures used in the study. 
 
4.1.2.1 Attention and Processing Speed  
This sample of participants demonstrated a significant impairment in the coding 
subtest – a measure of attention and processing speed. Previous studies have also 
indicated impairment in these domains (e.g. Rosca et al., 2011). However tests of 
simple attention (digit span forward and spatial span) fell within the low average 
range perhaps indicating that processing speed and motor function are more 
affected than simple attention in this sample. Again this is in keeping with previous 
research suggesting that simple attention deficits often present in the latter stages of 
disease (e.g. Grant, 2008; Heaton et al., 1995).   
 
Trails A and verbal production scores fell within the below normal range. These 
findings again provided support for the impact of HAND on processing speed. 
Baldewicz et al. (2004) note that tests of processing speed have good sensitivity to 
HAND. 
 
These results could have significant implications since Levine et al. (2008) report 
that processing speed impairments are linked to difficulties in completing activities of 
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daily living. Further, Harding and Hinkin (2002) highlight the importance of 
processing speed and attention in supporting higher order processes.  
 
4.1.2.2 Learning & Memory 
In terms of memory, list learning mean scores fell within the below normal range 
perhaps indicating poor strategic encoding techniques, and were therefore in line 
with previous studies in this area (Delis et al., 1995; Murji et al., 2003; Peavy et al., 
1994). However slightly stronger performances on the list recall test suggested that 
what is learned is retained.  
 
Performance in story memory tasks fell within the low average range. The slightly 
better performance on story tasks in comparison to list tasks may be attributable to 
the semantic processes supporting memory for stories, whilst list learning is more 
dependent on attentional processes.  
 
Grant (2008) and Woods et al. (2009) note that both story learning and list learning 
are sensitive to HAND, however this study found that participants performed slightly 
better on story learning than list learning, suggesting divergent sensitivity between 
the two tests; list learning appeared to be more sensitive and may be more clinically 
useful for those in the early stages of disease, while story-learning may be a more 
appropriate for those in latter stages. However since the tests measure slightly 
different functions, they may be most helpfully employed in combination.  
 
4.1.2.3 Visuo-Spatial Skills 
Visuo-spatial skills (as assessed by the figure copy, figure delayed recall, and line 
orientation tests) were intact, and therefore in keeping with the current literature 
base which suggests that the occipital and parietal lobes are not usually affected in 
the earlier stages of disease (ANI and MND stages; e.g. Heaton et al., 1995).  
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4.1.2.4 Language 
Additionally, language skills, as assessed by the picture-naming subtest were 
unimpaired indicating that simple expression deficits were not evident in this sample. 
Woods et al. (2009) report similar conclusions in their summary of the literature 
base.  
 
In summary, group level scores for the general cognitive battery were in keeping 
with the wider consensus in the current literature base. This is a useful finding in that 
it suggests, in spite of its relatively small size, the sample obtained may be 
considered typical of the wider HAND population in question.  
 
4.1.3 Executive Function Battery Analysis 
Working memory as assessed by digit span backwards was within the below normal 
range and in keeping with the current evidence base. For example Stout et al. 
(1995) found working memory deficits even in those with ANI. Notably however the 
two participants with ANI in this sample did not demonstrate impairments in this 
function.  
 
Letter fluency scores fell within the average range whilst category fluency scores fell 
within the low average range. These findings are not in keeping with the evidence 
base where impairments in frontostriatal regions (and therefore letter fluency) are 
documented early in disease, whilst impairments in temporal regions (associated 
with semantic memory storage) are thought to present only in latter stages of the 
disease (e.g. Grant, 2008; Rippeth et al., 2004). Closer inspection of individual case 
profiles suggests that participants either in the early stages of HAND, or who 
showed low levels of impairment (participants 1, 11, 15, 16) scored particularly 
highly on the letter fluency test and this may have affected the results. Further of the 
remaining twelve participants – all of whom showed clear evidence indicative of 
HAND – nine scored comparably or higher on letter fluency than category fluency, 
leaving only three profiles showing the reverse pattern. It is difficult to interpret this 
finding, however a meta-analysis conducted by Iudicello et al., (2007) found that 
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both category and letter fluency deficits were comparable once important variables 
have been controlled for (e.g. age and stage of disease). The authors conclude that 
this finding is likely the result of general damage to frontal systems.    
 
Verbal initiation and inhibition tasks (Hayling 1 & 2) yielded the lowest scores in the 
battery, indicating marked difficulties with verbal executive functions. This finding 
was consistent both at group level analysis and also in the individual case profiles; a 
number of participants who generally performed in the higher ranges scored within 
the below normal and impaired ranges for these tests (e.g. participants 1, 5, 11, 15, 
16). This finding is in keeping with research suggesting that language difficulties 
associated with HAND, especially in the earlier stages, are more likely to be linked to 
the effectiveness of executive control (Murji et al., 2003). However scores on Hayling 
1 (verbal initiation) were also impaired so deficits in inhibition may only account for 
some of this picture; poor initiation scores are likely to have been impacted by slow 
verbal output speed. 
 
Interestingly, studies using different tests have also reported difficulties in response 
inhibition in those with HAND e.g. the Stroop test (Tozzi et al., 1999). It may be the 
case that problems in this domain will prove to be a useful indicator of cognitive 
changes associated with HIV infection.  
 
Scores on a test of working memory and visuo-spatial rule deduction (Brixton) fell 
within the below normal range indicating difficulties in these functions. Individual 
profile examination confirmed that the majority of participants scored poorly on this 
test, with only the two participants with ANI scoring within the average ranges. To 
the best of the author’s knowledge, the current study is the first to find this pattern in 
a sample of participants with HAND. This finding may be explained by previous 
studies indicating that, in the earlier stages of disease, complex attention and 
working memory become impaired. The finding might further be explained by 
excessive rigidity as hypothesised by Shallice’s faulty attentional system theory, 
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since participants appeared to find it difficult to develop alternative strategies in light 
of changing patterns.  
 
Trails B scores fell within the low average range. Although Heaton et al. (1995) have 
previously reported impairments in this test in those with HAND, the findings of this 
study suggest that processing speed is impacted rather than the executive function 
ability show-cased in the test, since performances on both Trails A and coding fell in 
the below normal range. 
 
In summary – at group level – working memory, verbal initiation and verbal inhibition, 
rule induction, and processing speed appeared to be impaired in this sample. Verbal 
fluency, attention span, and visuo-spatial switching appeared to be intact. 
Consequently this is the profile of executive functions obtained from this sample of 
participants with HAND. In light of these results, it would be useful for clinicians 
working in this field to consider using digit span backwards, Hayling initiation, 
Hayling inhibition, and Brixton tests when assessing this client group. 
 
4.1.4 Correlations Between Tests 
Correlational analyses were undertaken to explore the data for associations between 
variables. Although these analyses do not lead to indications of causality, they 
highlight possible relationships, which may warrant further study. 
 
Tests of attention and information processing speed were correlated with 
performances on other tests (e.g. figure copy, figure delay, fluency); this is perhaps 
reflective of shared processes underpinning these tests e.g. attention, motor skills. 
Further, visuo-spatial skills were correlated with each other, as were tests of learning 
and memory. In all cases this is again likely to be the result of shared and 
interdependent skills.   
 
Further, executive functions were found to be correlated both with performances in 
other cognitive domains (attention, information processing speed, language, visuo-
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spatial skills, and memory) and with each other. Again this is not surprising given 
that many cognitive skills share core components and are interdependent (Hodges, 
2007). 
 
In summary correlational analyses highlighted the interdependent nature of cognitive 
functioning, and many variables were correlated with each other. The hypotheses of 
Dawes et al. (2008) may provide one useful explanation of these findings. They note 
that to greater or lesser degrees the following processes underpin test performance: 
attention/working memory, executive function, motor function, processing speed, 
and visual and verbal memory. 
However, the correlational analyses also resulted in some unexpected findings. For 
example, age was found to be associated with figure copy and spatial span. 
Interestingly levels of premorbid ability were found to be correlated with many tests 
however were not found to be correlated with verbal inhibition (Hayling 2). It is 
difficult to interpret these findings since complex executive skills would be expected 
to be linked to cognitive ability. Further, figure copy was found to be associated with 
list recall. As noted above, this is likely to be the result of shared cognitive processes 
required to complete each task.  
 
4.1.5 Individual Case Analyses 
Individual case analyses were undertaken for each participant to explore the 
possible impact of co-factors. This was deemed appropriate since descriptive 
analysis of group level data indicated large standard deviations, and the sample 
appeared to vary widely in terms of medical and background features. 
 
4.1.5.1 Demographic Factors 
As mentioned above, when examined individually, fourteen profiles showed clear 
evidence of mild neurocognitive disorder. There did not appear to be any patterns in 
terms of age, gender, or background within this group. 
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The remaining two participants showed evidence indicative of ANI since they had 
lower than expected scores on some of the executive function measures. This is 
further evidence that executive function difficulties are amongst the very earliest 
signs of HAND. One participant was born, raised, and schooled to graduate level in 
England and the other in America. Both had high premorbid ability scores. However, 
no other similarities between their profiles were found. 
 
4.1.5.2 Culture and Language 
Six participants in total were schooled in England and as mentioned one was 
schooled in America (participants 1, 2, 5, 11, 14, 15, and 16). Their levels of 
education varied; however all left formal education either at their sixteenth birthday 
or later except participant 5 who reported leaving school shortly after his tenth 
birthday. Broadly, the majority of these participants scored in the average ranges on 
most tests involving language throughout the assessment.  
 
Upon inspection it appeared that participants 3, 7 8, 9, 10, and 13 were the most 
impaired in the sample. Interestingly, as mentioned above all of these participants 
had English as their second language. Two of these participants scored within the 
average range in the picture-naming test (a test of simple expression and language 
ability). The remaining four scored within the below normal range. However all of 
these participants scored within the impaired ranges in the verbal production and 
fluency subtests. Consequently their performances may have resulted from the 
impact of English being their second language. This argument is in line with 
literature in this area (e.g. Shah, Oommen & Wuntakal, 2005). Further support for 
this viewpoint comes from the finding that (broadly speaking) these participants 
appeared to perform slightly better in tests with visuo-spatial components than those 
with language components (e.g. line orientation, figure copy, spatial span).  
Interestingly Siedlecki et al., (2010) have argued that Western educational systems 
highly value verbal abilities but other cultural systems value and nurture different 
cognitive skills; the results described above may be explained to some degree by 
this perspective. 
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4.1.5.3 Core Test Battery and Executive Function Battery 
In terms of the RBANS scores, except for the pattern described above, there did not 
appear to be any other consistent findings at individual profile level. Attention, visuo-
spatial perception, new learning and memory ability all appeared to vary widely 
between individuals. This finding is in keeping with those of Dawes et al. (2008) who 
also reported that their study did not find a ‘typical’ profile of impairment in those with 
HAND.       
 
Executive function deficits are also often reported to be highly variable both within 
individuals and between groups (Burgess & Alderman, 2012) and this was true of 
the sample obtained for this study.  Closer examination of individual profiles did not 
identify any patterns in executive functioning; for example executive verbal test 
scores did not consistently fair better than executive visuo-spatial scores or vice 
versa, and there did not appear to be any links with medical or psychological factors 
and performance on the executive battery. It may be the case that a bigger sample 
is needed to discover such patterns. However an interesting finding is that in the 
case of three individual profiles, performance on the digit span backwards test was 
stronger than the performance given by these participants in the digit span forwards 
test. Since the digit span forward test assesses attention, a skill often cited as being 
impaired by the pathological effects of HAND, it is likely that in these cases working 
memory ability was stronger whilst attention was more impaired.  
 
Further as noted throughout, the Hayling test, and the inhibition trial in particular, 
appeared to be the most difficult for participants in the majority of cases. 
 
4.1.6 Summary & Interpretation of Findings  
16 participants in varying stages of disease were assessed, and their scaled scores 
indicated that – at group level – they were typical of the wider HAND population. An 
executive function battery highlighted that verbal fluency, simple attention and visuo-
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spatial switching were intact whilst working memory, verbal initiation, verbal 
inhibition, complex attention, and processing speed were impaired in this sample.  
 
This finding is interesting in the context of the existing evidence base. Considering 
Shallice’s supervisory attentional systems theory, the finding that verbal fluency and 
visuo-spatial switching were less impaired indicates that the attentional system is 
able to maintain a degree of control over retrieval and working memory systems. 
Further it would appear that, in the case of letter fluency, the cognitive flexibility 
required to develop new rules is still intact.  
 
As mentioned above, Heaton et al. (1995) highlighted that performance on Trails B 
was impaired in their sample. However, the findings of this study show componential 
factors account for impairments found in this test. Further, previous research (e.g. 
Woods et al., 2009) has argued that working memory impairments present at the 
very earliest stages of disease, however the results of this study indicate that 
performance on digit span backwards was less impaired than digit span forwards – 
indicating that attention may be more impaired than working memory.  
 
As highlighted in section 3.4, participants in this study presented with a number of 
comorbid health conditions (e.g. toxoplasmosis and diabetes) and risk factors (e.g. 
substance use), which may have played a role in the profiles obtained in this study. 
These points were discussed within the context of individual case profiles, alongside 
relevant research. Consequently any conclusions drawn about the role of HIV-
associated cognitive decline need to be made with caution. The findings of the study 
appeared to suggest that many of the conditions explored resulted in impairments in 
domains similar to those affected by HAND e.g. processing speed, attention, and 
executive functions. However not all executive function skills were impaired equally 
in the current study, and this is a useful finding both at group level and at individual 
case level.  
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4.2 Clinical Implications 
 
Executive functioning is a broad term encapsulating higher order cognitive abilities; 
these include mental flexibility, initiation, planning, decision-making, and set shifting 
(Burgess & Alderman, 2012). These functions are central to formulating and 
achieving goals, to ensuring behaviour is appropriate and modifiable, and to 
maintaining independence (Burgess & Alderman, 2012; Duncan & Owen, 2000; 
Hodges, 2007). Executive functions are a key marker of HIV associated cognitive 
impairment (Dawes et al., 2008; Rosca et al., 2011) due to the predilection of the 
disease for frontrostriatal regions of the brain (e.g. Rippeth et al., 2004). These 
impairments can present at the earliest stages of disease (Vance, Fazeki & 
Gakumo, 2013). Of particular importance to the population in question is the effect 
that impaired executive functioning can have not only on the quality of life (e.g. the 
ability to maintain independence; Cattie et al., 2012) but also in situations dependent 
on maintaining optimal health and preventing disease progression e.g. medication 
adherence (Heaton et al., 2004).  
 
A criticism of the current literature base, and in turn clinical practice, that led to this 
study is that although executive function deficits are recognised as central to HIV, it 
is not often acknowledged that the term encompasses a ‘collection’ of functions; a 
test of a particular executive function is often considered to be representative of all 
executive abilities. In clinical settings clinicians may select tests on the basis of 
familiarity or convenience rather than on the basis of their clinical usefulness. 
Consequently it would be clinically informative to know whether particular functions 
are more impaired than others.  
 
The findings of this research provide some evidence to suggest that particular 
executive functions are more intact (e.g. verbal fluency, visuo-spatial switching) 
whilst others may be more impaired (verbal switching, initiation, and inhibition, verbal 
working memory, complex attention and rule deduction). Although this study did not 
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control for stage of disease, individual profile analyses highlighted that this picture 
was broadly similar at group and individual case level.   
 
The implication of this is that if only a single preserved or impaired skill is assessed, 
it may result in a clinician misinterpreting a presentation. In turn his could lead to a 
delay in receiving the appropriate care and treatment. Further, clinicians are often 
stretched for time and resources, and it would be unethical to assess participants 
with a number of tests without some hypothesis about what is being looked for. Use 
of an executive function battery, which has been developed based on current 
evidence in the field, could support clinicians in ensuring that the areas most likely to 
be impacted by HIV are assessed.  
 
Further, deficits in complex executive functions, for example working memory as 
assessed by digit span backwards and visuo-spatial switching as assessed by Trails 
B, may be attributed to higher levels of impairment without acknowledgment of the 
impact of componential processes. This study highlighted that comparing the 
performances of these tests to the performances given in digit span forwards and 
Trails A indicates that it may not be working memory and visuo-spatial switching that 
are impaired, but processing speed and attentional processes.  
 
A key implication of this is the need for clinicians to consider the impact of these 
componential factors when formulating their findings, since these may influence 
subsequent treatment planning e.g. when designing cognitive strategy programmes. 
This finding may also have implications for those working with other diseases which 
impact executive function e.g. Alzheimer’s disease. 
 
It may be beneficial for clinicians to retain an awareness of these issues when 
assessing this multi-faceted construct; profiles of executive functions can then be 
used to tailor appropriate strategies to support preservation of current levels of 
functioning. This is particularly important since gradual decline in one area can be 
coupled with decline in other areas given the highly interconnected nature of 
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cognitive processes and brain structures (Hodges, 2007).  Further Murji et al. (2003) 
have highlighted how other cognitive functions e.g. memory, are heavily dependent 
on executive function skills.  Consequently the importance of maintaining executive 
functioning cannot be underestimated both in terms of limiting impact on other 
cognitive domains, but also in terms of maintaining quality of life.  
 
Since HIV infection affects people from all over the world it is important for clinicians 
to find culturally sensitive measures in order to avoid making false positive 
diagnoses. This is perhaps a concern impacting the wider field of neuropsychology, 
since numerous studies have highlighted the effects of language and culture on test 
performance. As Manly et al. (2011) have noted, some attempts to account for 
cultural factors have been made, however developing complete batteries of 
appropriate tests for the wide variety of ethnic groups that use our services may be 
unrealistic; therefore use of culture fair tests may be a more achievable goal. On the 
basis of the findings of this study, it might be useful to assess for attention, 
processing speed, working memory, and visual-spatial switching if culturally 
appropriate tests are not available (e.g. coding, Trails tests, spatial span). However it 
is worthy of note that some researchers have argued that the very notion of a 
‘culture-fair test’ is a fallacy (e.g. Siedlecki et al., 2010). Although these arguments 
should not be ignored, it is also important to consider the useful ways in which 
clinicians are currently practicing whilst suitable solutions are being found. 
Consequently, formulation skills are central in ensuring that a patient’s context, in 
addition to test scores, are taken into account to obtain the clearest picture about 
what impairments the individual is experiencing. 
 
4.3 Critical Review 
 
4.3.1 Epistemological Perspective & The Wider Context 
As highlighted in the method section, a critical realist perspective was chosen by the 
researcher whilst conducting this study, though realist methods were utilised when 
collecting and analysing data. The perspective allows researchers to retain 
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awareness that perspectives (and therefore theories) are context-bound and 
therefore fallible; the approach was deemed appropriate after exploring ideas about 
the societal construction of diseases and the importance of keeping peoples ‘lived 
experiences’ in mind.  
 
In the view of the researcher it would be useful to retain awareness of these issues 
in clinical practice too. Constructs and theories change as our understanding of an 
area develops, however our diagnoses impact people’s lives, in terms of the labels 
that we give (and the stigma attached) and also in terms of the constrains and 
implications of these labels. For example we are gatekeepers of services and our 
labels can award support and treatment, but can also provide weight to decisions to 
constrict activities, such as driving.  
 
This is in line with the critiques of Sontag (1991) who highlights that societal models 
of coping with illness have inadvertent consequences including socially constructed 
realities (for example, diagnostic labels), which can isolate sufferers of a disease. 
Carlson (2005) presents a similar argument by noting that ‘lived realities’ are the 
combined result of actual cognitive deficits and the socio-political context in which a 
person lives. 
 
4.3.2 Sample & Test Material Limitations  
A number of factors will have affected methodological rigour of the study, and 
consequently the reliability and validity of the findings.  
 
Recruitment for this study took place within a limited timeframe from a single service. 
Consequently the sample obtained was small in size and, as mentioned throughout 
the report, varying in terms of age, ethnicity and background factors. The clinical 
presentations of the participants also varied greatly. Although this is reflective of the 
participants who would ordinarily use the service, given the small sample size, 
conclusions could only be drawn tentatively. However it may be argued that this is 
the nature of exploratory studies, in spite of the common belief that samples should 
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be tightly controlled for key variables. Another important consideration comes from 
Heaton et al. (2011) who have estimated that only as few as 7-10% of those with 
HAND will not present with comorbidities. Consequently to have tried to control the 
recruitment more rigorously may have negatively impacted not only the numbers 
obtained, but also the ecological validity of the findings.  
 
In spite of these limitations it is important to keep in mind that the aim of the study 
was to explore whether a particular phenomena could be observed in a particular 
population. It would have been unethical to run a large study without some evidence 
that such a phenomena exists in the first instance. Additionally, although the 
evidence base is clear about the impact of certain comorbidities on cognitive 
presentations, it is less clear of the impact of others. Further research into these 
areas is needed and ruling out participants to ensure clinical homogeneity would not 
have been ethical until more conclusive evidence is available. With these arguments 
in mind tentative conclusions can be considered to lay the foundations of future 
enquiry. 
 
Further, whilst the inclusion and exclusion criteria of the study attempted to control 
for the degree of impairment caused by more well-known comorbidities on cognitive 
functioning, it became clear that in order to obtain enough participants to conduct the 
study, the criteria had to be applied thoughtfully. This involved working closely with 
the consultant in the service, who was supportive and helpful in thinking through the 
suitability of patients for the study. Although this ultimately meant that someone 
other than the researcher decided which participants were suitable for the study, this 
arrangement felt manageable due to the consultant’s extensive knowledge about the 
field, and also given that he held a full overview of the patient’s conditions.  
 
It was sometimes difficult to obtain full histories from patients. Further, it was 
frequently reported by members of the multi-disciplinary team that patients often do 
not want their families or other members of their social networks to know that they 
are patients in a HIV rehabilitation unit. Some had only recently received their 
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diagnoses and others only recently arrived from other countries. This impacted the 
study in a number of ways e.g. it was not possible to obtain collateral information 
from others about the everyday functioning of patients to supplement medical and 
neuropsychological profiles. This additional information may have added a very 
useful dimension to the study.  
 
In fact, in the initial stages of the project, one of the questions this study proposed to 
answer was how well executive function impairments mapped onto impairments in 
everyday functioning. However this question had to be reviewed due a number of 
time and resource constraints. One of the issues included limited availability of 
collateral information from carers as discussed above. A further issue that became 
apparent is that the occupational therapists within the service no longer administered 
a single measure of functioning as part of the standard service assessment, and in 
order to answer a question about everyday functioning an additional measure (e.g. 
the Naturalistic Action Test; Shwartz, Segal, Veramonti, Ferraro, & Buxbaum, 2002) 
would have needed to be included in the study. This would have had time and 
resource implications since an additional test could take up to an hour to administer, 
and would require the use of additional facilities (a kitchen). However this may be a 
useful avenue for future studies to explore.   
 
Whilst participant factors can impact conclusions, factors associated with test 
materials can also influence the results. The Centre for Reviews & Dissemination 
(2008) notes that it is important for tests used for diagnostic purposes to be both 
sensitive (to the earliest stages of disease) and specific (i.e. able to discriminate 
between different diseases). An issue that is often overlooked in the field of 
neuropsychology is that many tests are unable to assess any given skill in a 
completely ‘pure’ manner; a fundamental premise of this study is the notion that 
tests, whilst assessing one skill often assess others, or can be dependent on other 
skills being intact (for example in the Brixton test both visuo-spatial perception and 
short term memory skills are required). There is therefore a possibility that the 
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results were reliant on the methods used to assess the skills and as more 
sensitive/pure tests become available (if ever) the results may change.  
 
It would also be useful to discuss the methods used to assess performances of 
participants. If time and resources had allowed, it would have been useful for this 
study to compare the performances of participants with those of matched healthy 
controls.  However, since this was not feasible, it was noted in the method section 
that published normative data was used by this study. However the normative data 
for each study was obtained using different samples, from different continents (E.g. 
the normative samples for the Hayling tests were obtained in the UK using only 118 
participants, whilst the DKEFS norms were obtained with 1750 American 
participants). This could have implications on the findings of this study. Firstly the 
ethnic diversity of this country differs significantly to that of America where, for 
example, Hispanic groups make up a significant proportion of the population. Further 
a significant number of the participants in this study had never been schooled in 
England and many of the tests used in this study have been reported to have 
significant positive correlations with education (E.g. the RBANS; Duff et al., 2003). 
Further education systems around the world differ in terms of their availability, 
quality and delivery styles, and this may also have impacted the results.  
 
Consequently, since a complete co-normed with battery with consistent normative 
data could not be used in this study, caution is needed when interpreting the data. 
Further, it is also useful to remember that a number of participants had low average 
or impaired premorbid ability estimates. It may be the case that this was a true 
reflection of their achievement levels, or indeed that reading ability was impaired. 
Consequently comparing them to population means (I.e. normative data) throughout 
the assessment battery may not have been instructive since their profiles would 
have fallen into the impaired ranges whether there was genuine impairment or not. If 
time and resources had allowed, it would have been useful to reassess participants 
again in the future to obtain truer profiles of impairment.  
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However the methods used by this study (a single assessment point using a number 
of different tests) are similar to those often used both in research and in clinical 
practice, where researchers and clinicians are only able to assess patients once, 
and are required to utilise different batteries to assess the skills of interest to them.  
 
In spite of the above, this study had a number of strengths. Firstly it utilised an 
executive function battery guided by previous research (Burgess et al., 1998; 
Cherner et al., 2007). Further it aimed to account for the impact of differing 
educational experiences by taking on board the recommendations of Manly et al. 
(2001) and using reading ability to measure premorbid functioning, in addition to 
level of education in the analyses. Finally Barker et al. (2003) note that small N 
studies are useful in combining research and practice, and this study has been able 
to make a number of recommendations that may enhance clinical practice. 
 
4.3.3 Professional Issues & Personal Reflections 
Whilst undertaking this research I held a dual role within the service – that of 
researcher and that of a trainee clinical psychologist. I found the service well 
accustomed to research, and the team supportive in ensuring the goals of the 
project were met.  
 
When negotiating the research with the team, it was agreed that a 
neuropsychological report would be written for each participant. Although this is fair 
and ethical given the time that participants were donating to the study, managing the 
demands of the research, the time necessary to write reports and to give feedback, 
and my clinical duties besides, was challenging at times. Conversely I learned first 
hand about managing the multiple roles that qualified psychologists often take on 
within services (Onyett, 2007). Additionally, since I was a clinician within the team, 
my position allowed me to take on a broader perspective of the difficulties that 
patients’ were presenting with, and the therapeutic utility of neuropsychological tests 
(and therefore the clinical utility of research into this area). Further, although the data 
obtained for the study was also used to inform patient care, I couldn’t help but be 
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drawn to the critiques of Ruff (2003) who notes that neuropsychology’s primary 
focus on assessment now needs to by matched by further developments in 
treatment approaches.  
 
Finally Speer (2002) highlights the importance of reflecting on the power in the 
relationship between the researcher and the researched and I wondered whether my 
dual role lead to some confusion or uncertainty for prospective participants about 
whether they had a choice in taking part in the research. However I feel confident 
that my fellow clinicians and I held this dilemma in mind when the research was 
being described to the patients, and maximised opportunities to ensure their 
informed consent e.g. discussing the research with participants on multiple 
occasions, showing each participant which assessments were part of the core 
service assessment and which tests were for study purposes before any 
assessment processes began. 
 
 
4.4 Future Research 
 
Although areas for future research have been indicated throughout the report, it 
would be useful to briefly revisit the issue here.   
 
Since this research established a profile of executive skill deficits based on a small 
sample, it would be useful to carry out the research with a larger sample in the 
future. This would allow more robust conclusions to be drawn, and would also allow 
for more control over demographic factors and co-morbidities (for example, age, 
stage of disease, point of cART initiation, English language levels). Further, in order 
to increase the robustness of the findings it would be useful to employ additional 
analytic measures which could support reliability and validity of the conclusions e.g. 
using inter-rater reliability measures with the WTAR.   
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As mentioned above, it would be useful to explore objective measures of daily 
functioning and their relationship to executive function tests. This would add to the 
literature in terms of increasing the ecological and predictive validity of executive 
function batteries.  
  
This study was only able to explore particular executive functions. Future studies 
may benefit from looking at the impact of processing speed and attentional 
processes in other higher order abilities e.g. reasoning, abstraction, problem-solving. 
Additionally, particular tests were used by this study; these are not the only 
measures available to assess executive functions and it may be useful for future 
studies to explore which tests are more sensitive in detecting particular executive 
deficits. For example the Mental Alternation Test (Salib & McCarthy, 2002) is a 
verbal equivalent of the Trails B test, and comparing sensitivity between the two 
tests may be a useful endeavor.  
 
Finally, as discussed above, HIV affects people from all over the world. To ensure 
that service delivery is equitable, it is important for future studies to explore culturally 
sensitive ways of assessing impairments across different groups. 
 
 
4.5 Conclusion 
To the best of the author’s knowledge this is the first study to explore a profile of 
executive function deficits in those with HIV associated neurocognitive decline. The 
findings suggest that verbal initiation, verbal inhibition, working memory and 
processing speed were impaired whilst simple attention, verbal fluency, and visuo-
spatial switching were intact in a mixed sample. The findings were then interpreted 
and discussed within the context of the existing evidence base.  
 
The clinical utility of the findings was explored and it was recommended that 
clinicians should consider the use of executive function batteries, rather than be 
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reliant on the results of a single measure, since the findings of this study indicate 
that certain skills are more impaired than others.  
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 Appendix A  
 
Stages of HIV Infection  
(Adapted from WHO HIV/TB manual, 2007, pp. 31-32) 
 
i. Acute Infection Phase 
Approximately 2-4 weeks, or even as long as three months after exposure to the 
virus 40-90% of people will experience extreme flu-like symptoms including 
lymphadenopathy, fever, joint pain, and rashes. Neurological diseases may also 
occur including meningitis.  
 
At this time, the virus inhabits CD4 cells to replicate and destroy them in the 
process, thus resulting in large amounts of virus being produced in the body.  
 
Many infected individuals may seek help however correct identification of the 
symptoms is seldom made, with clinicians often confusing the signs for other causes 
e.g. malaria. Further, standard serological tests only become positive 1-3 months 
post infection and hence at the stage an individual presents, the results are likely to 
be negative.  
 
ii. Asymptomatic HIV Infection/Clinical Latency 
Latency follows the initial infection phase where infected individuals can remain 
asymptomatic for longer than ten years. During this phase HIV reproduces at 
relatively low levels, with individuals able to maintain low viral loads and healthy CD4 
counts without the use of medications in the early years of this phase. It is also 
possible that there is an absence of other symptoms and opportunistic infections.  
 
iii. HIV Disease & AIDS 
Most, if not all, those infected by HIV will develop HIV-related diseases and AIDS if 
untreated. This phase is characterised by critically low levels of CD4 cells (below 
200 cells per cubic millimetre of blood). Consequently cell-mediated immunity is 
severely impaired and there is a high risk of opportunistic infection and tumours. 
 Early signs include weight loss, oral candidiasis and tuberculosis. Pneumonia and 
meningitis may present later however the rate of progression is dependant on virus 
and host characteristics. However all of these diseases can be fatal, with people 
diagnosed with AIDS typically surviving three years. However someone with a 
dangerous opportunistic infection has a likely life expectancy of one year. 
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UEL Ethics Committee Documentation 
 
SUPERVISOR:  Matthew Jones Chesters ASSESSOR: Rachel Smith 
 
STUDENT: Amardeep Johal   DATE (sent to assessor): 04/03/2013 
 
Proposed research topic: Executive Function Deficits in HIV-associated Neurocognitive 
Decline 
 
Course: Prof Doc Clinical Psychology 
 
 
1.   Will free and informed consent of participants be obtained?  YES* see below 
1 
 
2.   If there is any deception is it justified?     N/A 
 
3.   Will information obtained remain confidential?     YES  
 
4.   Will participants be made aware of their right to withdraw at any time? YES* see below 
2 
 
5.   Will participants be adequately debriefed?    YES* see below 
3 
 
6.   If this study involves observation does it respect participants’ privacy? NA 
 
7.   If the proposal involves participants whose free and informed 
      consent may be in question (e.g. for reasons of age, mental or 
      emotional incapacity), are they treated ethically?   NA 
 
8.   Is procedure that might cause distress to participants ethical?  YES * see below 
4 
 
9.   If there are inducements to take part in the project is this ethical? NA   
  
10. If there are any other ethical issues involved, are they a problem? NO  
 
APPROVED   
 YES, PENDING MINOR 
CONDITIONS 
 
 
MINOR CONDITIONS:   
ETHICAL PRACTICE CHECKLIST (Professional Doctorates) 
 1: It would be better on the consent form if the participant could tick a box to agree to each 
of the conditions rather than sign the whole form. 
 
2: When will data be destroyed? This should be in keeping with the data Protection Act and 
might include what you will do with the data of participants who withdraw. 
 
3: You say that a report will go to the team consultant – will it go to the participant too? What 
will be fed back to them straight after the session as the tests will take time to score? 
 
4: You might consider conducting the assessment over two shorter sessions for the benefit 
of the participants, or at least offering this. 
 
Assessor initials:  RS  Date:  7.3.13 
  
  
 
SUPERVISOR:  Matthew Jones Chesters ASSESSOR: Rachel Smith 
 
STUDENT: Amardeep Johal   DATE (sent to assessor): 04/03/2013 
 
Proposed research topic: Executive Function Deficits in HIV-associated Neurocognitive 
Decline 
 
Course: Prof Doc Clinical Psychology 
 
 
Would the proposed project expose the researcher to any of the following kinds of hazard? 
 
 
1 Emotional   NO 
 
 
2. Physical   Yes 
 
 
3. Other    NO 
 (e.g. health & safety issues) 
 
 
If you’ve answered YES to any of the above please estimate the chance of the researcher 
being harmed as:      LOW  
 
 
APPROVED 
 
 YES, PENDING MINOR 
CONDITIONS 
 
 
 
MINOR CONDITIONS: 
Think of the safety of you as a researcher and how you will ensure this. What type of room 
will you use? Who will know you are there? These are people you have never met before 
and might have very little information about. 
 
 
REASONS FOR NON APPROVAL:  
 
 
Assessor initials:  RS  Date:  6//3/13 
 
For the attention of the assessor: Please return the completed checklists by e-mail to 
ethics.applications@uel.ac.uk within 1 week. 
RESEARCHER RISK ASSESSMENT CHECKLIST (BSc/MSc/MA) 
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UEL Ethics Committee Approved Participant Information Sheet   
 
 
Who am I? 
My name is Amber Johal. I am a trainee clinical psychologist studying at the 
University of East London. My email address is u1138186@eastlondon.ac.uk. 
My phone number is XXXX XXXXX. 
What is the research about? 
My study aims to examine the impact of HIV infection on an individual’s ability 
to make plans and judgments, and on their ability to cope with tasks of 
everyday living. This information will help us to understand how HIV impacts 
the brain’s ability to cope with a variety of situations and tasks. 
This information will help us to develop new approaches to psychological 
assessment and intervention. 
What is required of me if I decide to take part? 
If you agree to take part, you will be asked to complete a set of psychological 
tests. It will take approximately 2.5 hours in total although this can be split 
into two sessions if you prefer. However you are allowed to withdraw from 
the study at any time if you later change your mind (and the information you 
have provided will be destroyed and not used).  
The assessments aim to explore a wide range of abilities e.g. problem-solving, 
remembering, comprehension and will involve a mixture of verbal responses 
and pen-and-paper exercises.  
What happens afterwards? 
You will receive feedback from the assessment approximately one week later 
 and you will also receive a written summary of the assessment. However I will 
be available to discuss any concerns or questions you have throughout the 
process. 
 
With your permission the results of the assessment will be fed back to the 
multidisciplinary team and will inform your care planning.  
 
What will happen to the information I provide? 
All the information you provide for the purposes of the study will be 
anonimised, and kept strictly confidential and separately from personal 
information the service holds about you.  
What will happen to the results of the research study? 
The results obtained from this research will be incorporated into a doctoral 
thesis that will be submitted to the University of East London. The thesis may 
be published in an academic journal in the future, however identifiable data 
on individual participants will not be included in any report or publication.  
   
Who can I contact if I have any questions? 
If you have any further questions, you can contact: 
• Amber Johal (XXXX Hospital and at the University of East London. Tel: 
XXXXX XXXXXXXX) 
• Dr Alison Jones (XXX Hospital. Tel: XXXX XXXXX) 
• Dr Matthew Jones Chesters (Clinical Psychologist at the University of 
East London. Tel: XXXXX XXXXXXXX)  
  
Thank you  
Amber Johal 
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UEL Ethics Committee Approved Consent Form  
UNIVERSITY OF EAST LONDON 
 
Consent to participate in a research study  
 
Executive Function Deficits In HIV-Associated Neurocognitive Decline 
Please read the following statements and tick if you agree.  
 1. I	  have	  the	  read	  the	  information	  sheet	  relating	  to	  the	  above	  research	  study	  and	  have	  been	  given	  a	  copy	  to	  keep.	  The	  nature	  and	  purposes	  of	  the	  research	  have	  been	  explained	  to	  me,	  and	  I	  have	  had	  the	  opportunity	  to	  discuss	  the	  details	  and	  ask	  questions	  about	  this	  information.	  I	  understand	  what	  is	  being	  proposed	  and	  the	  procedures	  in	  which	  I	  will	  be	  involved	  have	  been	  explained	  to	  me.	  (Tick	  box	  if	  you	  
agree ☐)	  
 2. I	  understand	  that	  my	  involvement	  in	  this	  study,	  and	  particular	  data	  from	  this	  research,	  will	  remain	  strictly	  confidential.	  Only	  the	  researcher(s)	  involved	  in	  the	  study	  will	  have	  access	  to	  identifying	  data.	  It	  has	  been	  explained	  to	  me	  what	  will	  happen	  once	  the	  research	  study	  has	  been	  completed.	  (Tick	  box	  if	  you	  agree ☐)	  
 3. I	  freely	  and	  fully	  consent	  to	  participate	  in	  the	  study	  which	  has	  been	  fully	  explained	  to	  me.	  Having	  given	  this	  consent	  I	  understand	  that	  I	  have	  the	  right	  to	  withdraw	  from	  the	  study	  at	  any	  time	  without	  disadvantage	  to	  myself	  and	  without	  being	  obliged	  to	  give	  any	  reason.	  	  (Tick	  box	  if	  you	  agree ☐)	  
 
Participant’s Name (BLOCK CAPITALS)  
………………………………………………………………………………………. 
 
Participant’s Signature  
……………………………………………………………………………………….. 
 
Researcher’s Name (BLOCK CAPITALS)  
……………………………………………………………………………………….. 
 
Researcher’s Signature  
 
………………………………………………………………………………………… 
 
Date: ……………………..…….  
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Table of Participant Characteristics 
 
No. Age Sex Ethnicity & 
Country 
of Birth 
Education 
(years) 
CD4 Viral 
Load 
Notes 
1 23 F Black British –  
England 
16 57 
 
59000 Longstanding 
history of chest 
infections and 
depression. 
Rectovaginal fistula 
2 46 M British Asian – 
England  
10 32 1196 History of 
substance misuse. 
TB 
3 40 F Black African – 
Nigeria 
7 177 202 Toxoplasmosis 
4 43 M Portuguese – 
Congo 
9 479 <40 TB 
5 57 M White British – 
England 
13 38 300000
0 
Pancytopenia, 
pneumocystis 
pneumonia, and 
Kaposi’s Sarcoma 
of the face, palette 
and tongue 
6 56 M Ghanaian – 
Ghana  
9 680 <40 Stroke in 2001. 
Toxoplasmosis. 
7 49 M Congolese – 
Congo 
15 75 916 TB 
8 48 M Ugandan – 
Uganda 
11 241 138613
2 
History of 
depression and 
PTSD. Tonic-clonic 
seizures 
9 54 F Zimbabwe – 
Zimbabwean 
4 2 100000
000 
 
10 47 F Ugandan –  
Uganda 
10 77 800000  
11 67 M White British – 
England 
17 180 140  
12 26 F Black British – 
Kenya 
10 4 110000
0 
Pneumocystis 
pneumonia, 
Toxoplasmosis, TB, 
delirium with 
psychotic features 
13 53 F St Lucian – St 
Lucia  
4 40 100000 Anxiety and 
depression 
14 50 M Black British – 
England 
11 991 <40 Hyperglycaemia 
15 72 M White British – 
England 
12 359 728 Frequent UTIs 
16 57 M White German – 
America 
17 300 <40 Chronic 
inflammatory 
demyelinising poly-
neuropathy 
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Table of Scaled Scores and Subjective Labels (Based on Slick, 2006) 
 
Scaled Score Subjective Range 
19 
Very Superior 18 17 
16 
15 Superior 14 
13 High Average 12 
11 
Average 10 
9 
8 Low Average 7 
6 Below Normal 5 
4 
Impaired  3 2 
1 
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Correlational Matrix 
 
Table G-1 Correlational Matrix 
 
    
Age 
(years) Education CD4 VL WTAR  
Age (years) 
 
rho      
Sig.       
Education 
 
rho 0.288     
Sig. 0.28     
CD4 
 
rho 0.271 0.192    
Sig. 0.31 0.476    
VL 
 
rho -0.185 -0.211 -.794**   
Sig. 0.494 0.433 0   
WTAR 
 
rho 0.38 0.431 0.454 -0.428  
Sig. 0.163 0.109 0.089 0.111  
Digit 
Forward 
 
rho 0.21 0.297 0.364 -.544* .565* 
Sig. 0.436 0.263 0.165 0.029 0.028 
Digit 
Backward 
rho 0.263 .704** 0.294 -0.26 .720** 
Sig. 0.324 0.002 0.269 0.33 0.002 
Coding 
 
rho 0.362 .557* 0.152 -0.25 0.402 
Sig. 0.168 0.025 0.575 0.351 0.137 
Figure 
Copy 
 
rho .542* .817** 0.18 -0.17 0.373 
Sig. 0.03 0 0.505 0.529 0.17 
Line 
Orientation 
rho -0.121 0.308 0.242 -0.473 0.43 
Sig. 0.656 0.246 0.366 0.064 0.11 
Picture 
Naming 
rho 0.463 0.364 0.239 -0.357 .517* 
Sig. 0.071 0.165 0.372 0.175 0.049 
List Total 
 
rho 0.357 .632** 0.273 -0.351 .614* 
Sig. 0.174 0.009 0.306 0.183 0.015 
List Delay 
 
rho 0.438 .545* 0.151 -0.278 .637* 
Sig. 0.09 0.029 0.576 0.296 0.011 
List 
Recognition 
 
rho 0.369 .529* -0.082 -0.113 0.49 
Sig. 0.16 0.035 0.763 0.678 0.063 
Story 
Immediate 
 
rho 0.412 .570* 0.441 -0.479 .636* 
Sig. 0.113 0.021 0.088 0.061 0.011 
Story Delay 
 
rho 0.315 .614* 0.322 -0.42 .611* 
Sig. 0.234 0.011 0.225 0.105 0.015 
Figure 
Delay 
 
rho 0.285 .786** 0.375 -0.466 0.503 
Sig. 0.285 0 0.153 0.069 0.056 
 
*= Correlation is significant at 0.05; **= Correlation is significant at 0.01 (2-tailed) 
  
 Table G-2 Correlational Matrix (continued) 
 
  
Age 
(years) Education CD4 VL WTAR  
Verbal 
Production  
rho 0.267 0.098 .578* -.675** 0.25 
Sig. 0.317 0.719 0.019 0.004 0.369 
Fluency - 
Letter  
rho 0.142 .638** 0.434 -0.482 .575* 
Sig. 0.601 0.008 0.093 0.059 0.025 
Fluency - 
Category  
rho 0.184 .669** 0.152 -0.259 .548* 
Sig. 0.495 0.005 0.574 0.332 0.035 
Fluency - 
Switches  
rho 0.162 .626** 0.056 -0.246 0.305 
Sig. 0.549 0.01 0.836 0.358 0.268 
Fluency - 
Output  
rho 0.146 .646** 0.041 -0.254 0.278 
Sig. 0.59 0.007 0.879 0.343 0.315 
Spatial 
Span  
  
rho .518* .624** .627** -.595* .584* 
Sig. 0.04 0.01 0.009 0.015 0.022 
Brixton  
  
rho 0.077 0.272 0.149 -0.334 0.448 
Sig. 0.778 0.308 0.583 0.206 0.094 
Hayling 1 
Basic  
rho 0.244 .562* -0.029 -0.116 0.435 
Sig. 0.363 0.024 0.916 0.67 0.105 
Hayling 2 
Inhib  
rho -0.292 0.455 0.031 -0.274 -0.095 
Sig. 0.273 0.076 0.909 0.304 0.737 
Trails A  
  
rho 0.296 .666** 0.136 -0.201 0.454 
Sig. 0.266 0.005 0.616 0.455 0.089 
Trails B  
  
rho 0.089 .514* 0.108 -0.256 0.247 
Sig. 0.742 0.042 0.691 0.338 0.375 
 
*= Correlation is significant at 0.05; **= Correlation is significant at 0.01 (2-tailed) 
 
  
 Table G-3 Correlational Matrix (continued) 
 
 
 
Digit 
Forward  
Digit 
Backward  Coding  
Figure 
Copy  
Line 
Orientation  
Picture 
Naming  
List 
Total  
Digit Forward rho        
Sig.        
Digit Backward rho .663**       
Sig. 0.005       
Coding rho 0.358 .525*      
Sig. 0.173 0.037      
Figure Copy rho 0.293 .640** .633**     
Sig. 0.27 0.008 0.008     
Line Orientation rho .696** .532* 0.226 0.203    
Sig. 0.003 0.034 0.401 0.451    
Picture Naming rho 0.277 0.288 0.428 .536* .502*   
Sig. 0.299 0.28 0.098 0.032 0.048   
List Total rho 0.426 .545* .782** .689** 0.277 .646**  
Sig. 0.1 0.029 0 0.003 0.3 0.007  
List Delay rho 0.322 0.425 .687** .614* 0.234 .728** .915** 
Sig. 0.224 0.101 0.003 0.011 0.384 0.001 0 
List 
Recognition 
rho 0.295 0.387 .690** .632** 0.159 .530* .755** 
Sig. 0.267 0.138 0.003 0.009 0.557 0.035 0.001 
Story 
Immediate 
rho 0.401 0.464 .670** .679** 0.389 .739** .854** 
Sig. 0.124 0.071 0.004 0.004 0.137 0.001 0 
Story Delay rho 0.424 0.472 .697** .657** 0.435 .720** .908** 
Sig. 0.102 0.065 0.003 0.006 0.092 0.002 0 
Figure Delay rho 0.436 .576* .745** .762** 0.459 .620* .863** 
Sig. 0.091 0.02 0.001 0.001 0.074 0.01 0 
Verbal 
Production 
rho 0.409 0.161 0.343 0.357 0.354 0.398 0.384 
Sig. 0.116 0.552 0.194 0.175 0.178 0.127 0.142 
Fluency - Letter  rho 0.482 .567* .644** .662** .519* .593* .827** 
Sig. 0.059 0.022 0.007 0.005 0.039 0.015 0 
Fluency - 
Category  
rho 0.481 .564* .624** .618* 0.486 .622* .882** 
Sig. 0.059 0.023 0.01 0.011 0.056 0.01 0 
Fluency - 
Switches  
rho 0.281 0.33 .588* .505* 0.216 0.386 .789** 
Sig. 0.291 0.211 0.017 0.046 0.421 0.14 0 
Fluency - 
Output  
rho 0.333 0.358 .606* .543* 0.279 0.398 .792** 
Sig. 0.207 0.173 0.013 0.03 0.295 0.127 0 
Spatial Span  rho 0.371 0.472 .646** .660** 0.381 .634** .625** 
Sig. 0.157 0.065 0.007 0.005 0.146 0.008 0.01 
Brixton  rho 0.378 0.231 0.287 0.113 0.168 0.318 .623** 
Sig. 0.149 0.39 0.28 0.677 0.534 0.23 0.01 
Hayling 1 Basic  rho .515* .665** .561* .688** 0.475 0.484 .745** 
Sig. 0.041 0.005 0.024 0.003 0.063 0.057 0.001 
Hayling 2 Inhib  rho 0.217 0.151 0.317 0.307 0.465 0.244 0.471 
Sig. 0.419 0.577 0.232 0.248 0.07 0.362 0.066 
Trails A  rho .567* .661** 0.493 .709** .568* .544* .676** 
Sig. 0.022 0.005 0.052 0.002 0.022 0.029 0.004 
Trails B  rho 0.338 0.468 0.467 0.476 .704** .559* 0.482 
Sig. 0.2 0.067 0.068 0.062 0.002 0.024 0.059 
 
*= Correlation is significant at 0.05; **= Correlation is significant at 0.01 (2-tailed)  
 Table G-4 Correlational Matrix (continued) 
 
 
 
List 
Delay  
List 
Recognition  
Story 
Immediate  
Story 
Delay  
Figure 
Delay  
Verbal 
Production  
Fluency 
- Letter  
List Delay rho        
Sig.        
List Recognition Sig. .806**       
rho 0       
Story Immediate Sig. .813** .749**      
rho 0 0.001      
Story Delay Sig. .873** .749** .963**     
rho 0 0.001 0     
Figure Delay Sig. .792** .709** .894** .912**    
rho 0 0.002 0 0    
Verbal 
Production 
Sig. 0.249 0.364 .621* .501* 0.48   
rho 0.353 0.166 0.01 0.048 0.06   
Fluency - Letter  Sig. .757** .650** .910** .922** .945** .536*  
rho 0.001 0.006 0 0 0 0.032  
Fluency - 
Category  
Sig. .820** .760** .764** .843** .840** 0.363 .804** 
rho 0 0.001 0.001 0 0 0.167 0 
Fluency - 
Switches  
Sig. .708** .708** .599* .700** .731** 0.329 .611* 
rho 0.002 0.002 0.014 0.003 0.001 0.214 0.012 
Fluency - Output  Sig. .698** .717** .618* .722** .763** 0.361 .648** 
rho 0.003 0.002 0.011 0.002 0.001 0.169 0.007 
Spatial Span  Sig. .650** 0.459 .745** .708** .783** 0.466 .726** 
rho 0.006 0.074 0.001 0.002 0 0.069 0.001 
Brixton  Sig. .659** .569* 0.439 0.488 0.493 0.146 0.463 
rho 0.006 0.021 0.089 0.055 0.052 0.589 0.071 
Hayling 1 Basic  Sig. .653** .606* .615* .708** .669** 0.353 .672** 
rho 0.006 0.013 0.011 0.002 0.005 0.18 0.004 
Hayling 2 Inhib  Sig. 0.33 0.364 0.476 .567* .664** 0.393 .633** 
rho 0.212 0.166 0.062 0.022 0.005 0.132 0.008 
Trails A  Sig. .588* .553* .567* .643** .675** 0.384 .628** 
rho 0.017 0.026 0.022 0.007 0.004 0.142 0.009 
Trails B  Sig. 0.391 0.4 .523* .561* .638** 0.464 .566* 
rho 0.134 0.124 0.038 0.024 0.008 0.07 0.022 
 
*= Correlation is significant at 0.05; **= Correlation is significant at 0.01 (2-tailed) 
 
  
 Table G-5 Correlational Matrix (continued) 
 
 
 
Category 
Fluency  
Fluency - 
Switches  
Fluency 
- Output  
Spatial 
Span  Brixton  
Hayling 
1 Basic  
Hayling 
2 Inhib  
Fluency - 
Category  
rho        
Sig.        
Fluency - 
Switches  
Sig. .883**       
rho 0       
Fluency - 
Output  
Sig. .896** .993**      
rho 0 0      
Spatial Span  Sig. .533* 0.395 0.405     
rho 0.034 0.13 0.12     
Brixton  Sig. .686** .700** .666** 0.206    
rho 0.003 0.003 0.005 0.445    
Hayling 1 
Basic  
Sig. .795** .667** .709** 0.331 0.343   
rho 0 0.005 0.002 0.21 0.193   
Hayling 2 Inhib  Sig. .639** .699** .748** 0.207 0.389 .537*  
rho 0.008 0.003 0.001 0.442 0.137 0.032 . 
Trails A  Sig. .855** .715** .749** .507* 0.351 .855** 0.497 
rho 0 0.002 0.001 0.045 0.182 0 0.05 
Trails B  Sig. .698** .607* .646** 0.419 0.211 .690** .694** 
rho 0.003 0.013 0.007 0.106 0.434 0.003 0.003 
 
*= Correlation is significant at 0.05; **= Correlation is significant at 0.01 (2-tailed) 
  
 Table G-6 Correlational Matrix (continued) 
 
  Trail A  Trail B  
Trails A  Sig.   
rho   
Trails B  Sig. .759**  
rho 0.001  
 
*= Correlation is significant at 0.05; **= Correlation is significant at 0.01 (2-tailed) 
 
 
 
 
 
